syndrome	score	normalized_score
DRAVET SYNDROME	2.948202999999999	100.0
CHILDHOOD ABSENCE EPILEPSY	2.52074085	85.50092547901217
AURICULOCONDYLAR SYNDROME	2.333878554	79.16274944432256
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.14424481624911
TOWNES-BROCKS SYNDROME 1; TBS1	1.713722434	58.12769453121106
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.668477704	56.59304003150396
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	1.645175719	55.80266077335925
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.56402327	53.05005354108929
CORNELIA DE LANGE SYNDROME 1	1.509313349	51.19434954105944
OROFACIODIGITAL SYNDROME TYPE 4	1.350545554	45.809109956132616
MYOCLONIC-ASTASTIC EPILEPSY	1.3442351540000002	45.59506770734581
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.31295385	44.53403819207837
PALLISTER-HALL SYNDROME	1.280121434	43.42039656020974
LENNOX-GASTAUT SYNDROME	1.2670541100000001	42.977166429855764
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	1.255422489	42.5826338620509
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	40.488867286275756
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.1641561139999999	39.486972708460044
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	39.07859329903675
ALLAN-HERNDON-DUDLEY SYNDROME	1.1321738899999998	38.402168710906274
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1292528	38.303088355856104
EARLOBE CREASE	1.125	38.15883777338265
TRISOMY 8P	1.1033231989999999	37.42358307755607
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.10140108	37.35838678679861
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.081343814	36.6780650450461
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686937	36.248986246876505
SLC35A2-CDG	1.0528196039999997	35.710553309931505
BENIGN OCCIPITAL EPILEPSY	1.027027	34.835694828341204
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	1.022863704	34.69448012908203
ROLANDIC EPILEPSY	1.021574	34.65073470178276
JOUBERT SYNDROME 1	1.016462574	34.47736041242751
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	1.0151217989999999	34.431882709569194
RETT SYNDROME; RTT	1.010342529	34.2697748085868
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00689655	34.152890760914374
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.001086973	33.955835910892176
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	33.918966909673465
EARRING HOLES, NATURAL	1.0	33.918966909673465
CRYPTOTIA, FAMILIAL	1.0	33.918966909673465
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	33.918966909673465
HAIRY EARS	1.0	33.918966909673465
HEREDITARY ANGIOEDEMA TYPE 1	1.0	33.918966909673465
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	1.0	33.918966909673465
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	33.918966909673465
RELAPSING POLYCHONDRITIS	1.0	33.918966909673465
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	31.81222731270541
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.23057842353462
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.9172414	31.111880694782563
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.8999999999999999	30.527070218706115
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8876050639999998	30.106646794674592
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.842211884	28.56695702432975
LAFORA DISEASE	0.78884221	26.756712817943683
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.13853591492853
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	25.75834872971774
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.7509319039999999	25.470834403194086
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.74700873	25.337764394107197
EARLY MYOCLONIC ENCEPHALOPATHY	0.7191456139999999	24.3926762845028
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.7	23.743276836771425
XQ12-Q13.3 DUPLICATION SYNDROME	0.68797398	23.33536666233635
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.684486754	23.2170835590358
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.683184133	23.172900000440954
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.67494477	22.893429319487165
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	22.84322463548135
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.6723690740000001	22.806064372093793
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.666667	22.612655912771277
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644	21.937580281954812
SPINOCEREBELLAR ATAXIA TYPE 10	0.62473414	21.19033662200331
BILATERAL POLYMICROGYRIA	0.624002104	21.16550671714262
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.6122079800000001	20.765462215458037
CENTRALOPATHIC EPILEPSY	0.6047009000000001	20.510829817349766
TRISOMY 18	0.602176874	20.425217462976605
ADNP SYNDROME	0.598979939	20.31678073049923
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5967571999999999	20.241387719909383
SCALP-EAR-NIPPLE SYNDROME	0.58473095	19.833469744111927
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.5840166	19.809239730100003
SCALP-EAR-NIPPLE SYNDROME; SENS	0.57965635	19.6613445546321
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.57496951	19.502371783761163
PERIORAL MYOCLONIA WITH ABSENCES	0.56570971	19.188288933970973
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.550630819	18.676828529107397
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5428161300000001	18.41176235150701
BRACHYDACTYLY TYPE A2	0.537037	18.21574023227031
OTOONYCHOPERONEAL SYNDROME	0.5353489699999999	18.15848399855777
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.09010437883688
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.52753378	17.89340082755496
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	17.87621137350448
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.5259578189999999	17.839945858545022
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.689418401650094
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.516670419	17.524926845268123
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.515625	17.48946731280038
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.514004494	17.434501423409454
PETERS-PLUS SYNDROME; PTRPLS	0.5128741330000001	17.396160746054466
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.512368214	17.379000496234493
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.507846503	17.225628730450385
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.19834929955638
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.5068881930000001	17.19312384527118
PETERS PLUS SYNDROME	0.506868234	17.192446856610626
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.50512821	17.133427040132588
DISTAL MYOTILINOPATHY	0.50492611	17.126572016920143
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5027027	17.051156246703506
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.50235294	17.03929274883718
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.501086973	16.99635245605544
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	16.977988082910173
MEDULLOBLASTOMA	0.500545554	16.977988082910173
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	16.977847827982
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	16.977847827982
PAROXYSMAL HEMICRANIA	0.5	16.959483454836732
CREST SYNDROME	0.5	16.959483454836732
PYKNOACHONDROGENESIS	0.5	16.959483454836732
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	16.959483454836732
INHALATIONAL ANTHRAX	0.5	16.959483454836732
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	16.959483454836732
BRACHYDACTYLY TYPE C	0.5	16.959483454836732
BRACHYDACTYLY, TYPE D	0.5	16.959483454836732
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	16.959483454836732
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	16.959483454836732
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	16.959483454836732
MADELUNG DEFORMITY	0.5	16.959483454836732
POLAND SYNDROME	0.4888886	16.582596245916587
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.48631315	16.49523964258907
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.36650054287307
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.47424667	16.08595710675283
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44171741999999997	14.982598552406333
MYOCLONIC EPILEPSY OF INFANCY	0.43886191399999996	14.88574273888196
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.43886191399999996	14.88574273888196
PSEUDOAMINOPTERIN SYNDROME	0.433676484	14.70985831029953
CZEIZEL-LOSONCI SYNDROME	0.43333299999999997	14.69820768786953
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.41217954	13.98070417810443
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40699812	13.80495576457931
BECKWITH-WIEDEMANN SYNDROME	0.4061966	13.777769034221867
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.4020878700000001	13.63840515731109
NEUROFACIODIGITORENAL SYNDROME	0.40031170000000005	13.57815930585513
DISTAL MONOSOMY 12Q	0.394864554	13.39339774092897
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.38830560000000003	13.170924797240902
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.383358539	13.003125598881764
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.380952	12.921498282173927
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.37778141899999995	12.813955450150486
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36420503	12.35345836090663
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35752487	12.126874234915306
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.126629679163885
SPINOCEREBELLAR ATAXIA TYPE 42	0.35743284000000003	12.12375267239061
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.350022833	11.87241289015716
GLOMUVENOUS MALFORMATION	0.35	11.871638418385713
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.349484243	11.854144473769281
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.346615073	11.756825191481052
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.346069519	11.738320563407612
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.714690406325484
NON-DISTAL MONOSOMY 20Q	0.344083579	11.670959530263014
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.342711979	11.624436275249707
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.34166633	11.588968941419573
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.545176841621833
FRAXE INTELLECTUAL DISABILITY	0.34017264999999997	11.538304858925931
MARTSOLF SYNDROME	0.33947207	11.514541909088354
FG SYNDROME 2; FGS2	0.33879748	11.491660513200756
PRIMROSE SYNDROME; PRIMS	0.33872228	11.489109806889148
KEUTEL SYNDROME; KTLS	0.337458649	11.446248748814112
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.335509874	11.380148314074713
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.334419973	11.343179998120892
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.33395510400000006	11.327412121892563
COG4-CDG	0.333878554	11.324815624975624
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.324675370047451
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.324675370047451
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.306310996902184
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	11.306310996902184
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.306310996902184
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.333333	11.306310996902184
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	11.306310996902184
PLACENTAL INSUFFICIENCY	0.333333	11.306310996902184
BRACHYDACTYLY, TYPE A6	0.333333	11.306310996902184
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	11.306310996902184
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.327464519	11.107258184053137
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32742392	11.10588110791557
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.08889381090787
RING CHROMOSOME 7 SYNDROME	0.32036969	10.866608913972344
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.31529217	10.69438468110914
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.31314179999999997	10.621446352235585
JUVENILE MYOCLONIC EPILEPSY	0.31234589999999995	10.594450246472176
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.30897985	10.48027730790587
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.30157221999999995	10.229018151056763
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.219154311965632
SCHINZEL-GIEDION SYNDROME	0.2986447	10.129719697049358
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.298125454	10.112107409157378
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.023692873251946
CHROMOSOME 1P36 DELETION SYNDROME	0.294566473	9.991390450386222
SAETHRE-CHOTZEN SYNDROME	0.294161199	9.97764397499087
ABLEPHARON-MACROSTOMIA SYNDROME	0.2911642	9.875988865081545
OTOONYCHOPERONEAL SYNDROME	0.28061503000000004	9.518171916927027
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.274006144	9.294005331383222
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.269751594	9.14969539071767
ZIMMERMANN-LABAND SYNDROME	0.26901346899999995	9.124658953267465
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.268915084	9.12132183570806
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.2659091	9.019361963881051
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.26196832000000003	8.885694777462751
LANDAU-KLEFFNER SYNDROME	0.259858903	8.814145532041046
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.259541069	8.803364931112277
8Q24.3 MICRODELETION SYNDROME	0.257848933	8.74596942612161
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25693326	8.714910743934528
20Q13.33 MICRODELETION SYNDROME	0.256680489	8.706337012749804
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25564458	8.67120004965737
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25531915	8.660161800255956
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.624694432506855
LAING EARLY-ONSET DISTAL MYOPATHY	0.25344828	8.596703822633655
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.546380286567787
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535	8.533175971939519
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535	8.533175971939519
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.516610728637074
EAR-PATELLA-SHORT STATURE SYNDROME	0.250545554	8.498246355491807
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.498106100563634
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	8.479741727418366
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	8.479741727418366
VACTERL WITH HYDROCEPHALUS	0.25	8.479741727418366
HYPERPARATHYROIDISM 2	0.25	8.479741727418366
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	8.479741727418366
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	8.479741727418366
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	8.479741727418366
DYSTONIA 6, TORSION	0.25	8.479741727418366
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.24496114400000005	8.308828937491757
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.243840536082491
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.23972188400000002	8.13111865092058
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23932652000000001	8.117708312487306
KOOLEN-DE VRIES SYNDROME; KDVS	0.238957923	8.105205883041299
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	7.9578917733955254
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23387798	7.932899464521273
8Q22.1 MICRODELETION SYNDROME	0.23192199400000002	7.866554440111488
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.22901783000000003	7.768048197495224
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.226086973	7.668636555895238
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	7.6632833627806525
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.225545554	7.650272182749969
BRANCHIOOCULOFACIAL SYNDROME	0.224379069	7.610706216634338
PIERPONT SYNDROME	0.22318961299999998	7.570361097929826
CODAS SYNDROME	0.222744554	7.555265156435974
DISTAL 17P13.1 MICRODELETION SYNDROME	0.22135945	7.508283859693518
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.22098719400000003	7.495657320747591
DOWN SYNDROME	0.22033085000000002	7.473394810330228
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.21929903900000003	7.438396847164191
CLASSICAL EHLERS-DANLOS SYNDROME	0.21898046	7.427590976605073
AURICULOOSTEODYSPLASIA	0.21787023	7.3899331219729465
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.21740343	7.374099748219512
COHEN-GIBSON SYNDROME; COGIS	0.217252574	7.368982868547386
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.216853483	7.355446114124438
WARBURG MICRO SYNDROME 2; WARBM2	0.21619997000000002	7.333279628302396
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.215078889	7.295253718960332
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.214545704	7.277168634588597
8P INVERTED DUPLICATION/DELETION SYNDROME	0.21349769899999999	7.241621387672424
INTELLECTUAL DISABILITY, WOLFF TYPE	0.21349769899999999	7.241621387672424
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.21237721	7.203615558358773
FGFR2-RELATED BENT BONE DYSPLASIA	0.21175792000000002	7.182609881341281
DEND SYNDROME	0.209883219	7.119021960156749
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.20986120000000003	7.118275098424364
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.208107573	7.0587938822394545
SHELDON-HALL SYNDROME	0.20742912000000002	7.0357814573826865
BRANCHIOSKELETOGENITAL SYNDROME	0.206620269	7.00834606707883
KAGAMI-OGATA SYNDROME	0.206406123	7.001082455990991
NEONATAL MARFAN SYNDROME	0.20612263	6.991466666304867
RENPENNING SYNDROME	0.20575696899999998	6.979063822945708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.205467529	6.969246317163373
FAMILIAL LAMBDOID SYNOSTOSIS	0.20546448	6.969142898233266
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.20540101000000002	6.966990061403509
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.20505564	6.955275467801915
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.20492611000000002	6.950881944018104
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.204129784	6.923871388774792
MOMO SYNDROME	0.20397778900000002	6.918715875399356
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.20376969	6.911657372304419
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.20368050000000001	6.9086321396457455
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.900755477149982
CODAS SYNDROME	0.203439913	6.900471677153848
XQ25 MICRODUPLICATION SYNDROME	0.202718293	6.87599507225249
DISTAL TRISOMY 6P	0.20218238400000002	6.857817592614894
RING CHROMOSOME 8 SYNDROME	0.20163132	6.839126071033781
1P21.3 MICRODELETION SYNDROME	0.20054555400000001	6.8022980100081325
BECKWITH-WIEDEMANN SYNDROME	0.2	6.783793381934693
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	6.783793381934693
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.783793381934693
RADIATION PROCTITIS	0.2	6.783793381934693
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	6.783793381934693
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	6.783793381934693
EAR PITS, POSTERIOR HELICAL	0.2	6.783793381934693
MUCKLE-WELLS SYNDROME	0.19444430000000001	6.5953497774746195
TOWNES-BROCKS SYNDROME	0.19050465	6.461720919488926
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18830818400000002	6.387219061916702
20Q11.2 MICRODUPLICATION SYNDROME	0.18818287299999997	6.3829686422542835
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.37561640090591
BRANCHIOGENIC DEAFNESS SYNDROME	0.1851855	6.281300846651335
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.18414040299999998	6.245852236090935
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.18347613999999998	6.223321121374615
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.206102836202258
MOWAT-WILSON SYNDROME; MOWS	0.182635449	6.194805751164355
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.177931234721628
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.078329205960379
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.17793815000000002	6.035478221818514
UNILATERAL POLYMICROGYRIA	0.17776205	6.02950509174572
3MC SYNDROME	0.17750715	6.0208591470804445
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.17724381899999997	6.011927231605151
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.1769231	6.001048774456849
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.176753623	5.995300289701898
MONOSOMY 9Q22.3	0.17546384299999998	5.951552284561139
PFAPA SYNDROME	0.17543893000000002	5.95070726133852
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.17465101400000002	5.923981964606917
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.173769243	5.894073203236007
CEREBROOCULONASAL SYNDROME	0.17188255000000002	5.830078525800295
ROIFMAN SYNDROME; RFMN	0.17106678400000003	5.802408585840259
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.17086195	5.795460828172282
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.17027323	5.775492053973219
MICROTRIPLICATION 11Q24.1	0.1693697	5.744845249801322
AREDYLD SYNDROME	0.16871618000000002	5.722678526546512
BRACHYDACTYLY, TYPE E	0.16871618000000002	5.722678526546512
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.167990874	5.6980768963331245
TARP SYNDROME	0.167382213	5.677431744014915
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.671536831079815
BRACHYDACTYLY, TYPE B1	0.166667	5.653172457934548
268650 RUDIGER SYNDROME	0.166667	5.653172457934548
PITYRIASIS RUBRA PILARIS	0.166667	5.653172457934548
PEMPHIGUS VULGARIS	0.166667	5.653172457934548
AURICULOOSTEODYSPLASIA	0.166667	5.653172457934548
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	5.653172457934548
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	5.653172457934548
HOLT-ORAM SYNDROME	0.166667	5.653172457934548
BRACHYDACTYLY TYPE B2	0.166667	5.653172457934548
BRACHYDACTYLY TYPE E	0.166667	5.653172457934548
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.653172457934548
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.653172457934548
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	5.653172457934548
BRACHYDACTYLY TYPE B	0.166667	5.653172457934548
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	5.653172457934548
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	5.653172457934548
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	5.653172457934548
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	5.653172457934548
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	5.653172457934548
49,XYYYY SYNDROME	0.1666667	5.653162282244474
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.1666667	5.653162282244474
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.16594129999999999	5.628557463648197
JUVENILE ABSENCE EPILEPSY	0.16503685	5.597879454026743
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.16323018399999997	5.536599209755909
ATYPICAL RETT SYNDROME	0.162472419	5.510896603795603
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.410268560204304
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.410268560204304
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1594828	5.409491815862071
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.1594828	5.409491815862071
608028 THAI SYMPHALANGISM SYNDROME	0.15922215	5.400650837137065
MOWAT-WILSON SYNDROME	0.157510249	5.342584923765427
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.299055390690534
DISTAL MONOSOMY 9P	0.155828444	5.285539835621904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.253941265238521
TEEBI-SHALTOUT SYNDROME; TBSH	0.15466734000000001	5.246156387467215
CHARGE SYNDROME	0.1536391	5.211279548932012
FEBRILE CONVULSIONS, FAMILIAL, 9	0.153624	5.210767372531676
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.178131017436724
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.159626389363284
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.15181360400000002	5.149360610514272
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.14891951	5.051195931894786
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.035382570331827
OLIVER SYNDROME	0.14795135	5.018356944891518
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.003495485215911
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.003495485215911
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.147406763	4.999885116459078
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.145058844	4.920246129591485
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.144158203	4.88969731731499
PHACE SYNDROME	0.14394397299999998	4.882430857033929
ALG11-CDG	0.14394397299999998	4.882430857033929
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.143244119	4.858692532366328
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	4.845561855815221
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.845561855815221
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.845561855815221
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	4.845561855815221
GANGLIONEUROMA	0.14285699999999998	4.845561855815221
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.141153799	4.787791037455699
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.140625	4.769854721672831
16P12.1P12.3 TRIPLICATION SYNDROME	0.14011800000000002	4.752657805449627
C SYNDROME	0.13912147899999996	4.718856842625831
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.13790635899999998	4.677641227554549
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.137708673	4.670935922662044
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	4.666120480848844
ATYPICAL JUVENILE PARKINSONISM	0.13756617899999998	4.666102673391216
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.13703700000000002	4.648153468400923
CHRISTIANSON SYNDROME	0.13649015	4.629604881346368
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13553973	4.597367616816076
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.13549420399999998	4.595823421928545
ZECHI-CEIDE SYNDROME	0.134640944	4.566881724223198
CONGENITAL MYASTHENIC SYNDROME	0.133985949	4.544664970492196
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.133985949	4.544664970492196
TEMTAMY SYNDROME; TEMTYS	0.132643903	4.4991441566269375
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.45717048656419
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.454663196530227
EHLERS-DANLOS SYNDROME, TYPE I	0.13090481999999998	4.44015625789676
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.13081887	4.437240922690874
22Q11.2 MICRODUPLICATION SYNDROME	0.12952334299999999	4.393297985247285
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.12939744900000003	4.389027790827161
LAURENCE-MOON SYNDROME	0.1286805	4.364709621420236
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.128380094	4.354520160246769
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.12750605899999998	4.324873796003872
HEART-HAND SYNDROME TYPE 2	0.12704918	4.309376932321149
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.12704918	4.309376932321149
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.12680505	4.301096294929489
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.126057584	4.275743020409383
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.125541419	4.258235236854451
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.125541419	4.258235236854451
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.125	4.239870863709183
PARKINSON DISEASE, LATE-ONSET; PD	0.125	4.239870863709183
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.125	4.239870863709183
PERRY SYNDROME	0.125	4.239870863709183
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.125	4.239870863709183
SECKEL SYNDROME	0.12497225000000001	4.23892961237744
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	4.199490333603217
TRISOMY XQ28	0.12359801	4.19231681129149
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.12318382900000002	4.178268219657875
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.12275444399999998	4.163703924051363
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.12240386899999998	4.151812782227005
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12096990299999999	4.103174136923409
MENTAL RETARDATION, X-LINKED 21	0.12058098899999999	4.089982575826699
GALLOWAY-MOWAT SYNDROME	0.12045510299999998	4.085712652758308
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.11976801300000002	4.062407269784342
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.118300879	4.012643600186284
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.007636177020376
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.11810906400000001	4.006137433548506
20P13 MICRODELETION SYNDROME	0.116629819	3.955962971342205
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.11469522999999998	3.8903437110673864
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.11469522999999998	3.8903437110673864
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.113955543	3.8652542921908712
XIA-GIBBS SYNDROME	0.113461604	3.848500391594474
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.11340077400000002	3.8464371008373597
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11316017999999999	3.838276400912692
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11274232	3.824103021399816
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.1121951	3.8055418843275053
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.11182266	3.7929091042916667
MAST CELL SARCOMA	0.11111099999999999	3.7687703323007278
TETRAPLOIDY	0.11111099999999999	3.7687703323007278
STEINERT MYOTONIC DYSTROPHY	0.11111099999999999	3.7687703323007278
ULNAR-MAMMARY SYNDROME	0.11111099999999999	3.7687703323007278
TARP SYNDROME; TARPS	0.11053204400000001	3.7491327428945715
14Q12 MICRODELETION SYNDROME	0.11028266900000001	3.7406742005214717
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.11	3.7310863600640807
SAGLIKER SYNDROME	0.10961538000000001	3.718040447011283
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.109075683	3.699734482327033
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.108995054	3.696999629944072
SPINOCEREBELLAR ATAXIA TYPE 29	0.108777964	3.689636161417651
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.10833333	3.6745546354847356
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.10793651000000001	3.661094911035639
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.107394603	3.642713985434519
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.107320054	3.640185360370369
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.6364731329559072
NAGER SYNDROME	0.1071242	3.633542195025242
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.62115037533033
MATERNAL PHENYLKETONURIA	0.106732113	3.6202430090465287
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10657480000000001	3.6149071146050678
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.10615581300000002	3.600695508416485
MICROTIA	0.10531915	3.5723167638049356
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.10492611	3.558985253050758
TRISOMY 13	0.104648429	3.5495666004003126
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.104129784	3.5319746978074456
AICARDI SYNDROME; AIC	0.1036867	3.5169457462732394
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.10361188900000001	3.51440823443976
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.10358423	3.513470069734005
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.10317752300000001	3.4996749884590725
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.4971879480483548
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.10270270000000001	3.483569482834121
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.10270270000000001	3.483569482834121
WEYERS ACROFACIAL DYSOSTOSIS	0.10204918	3.4614027595793107
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10196464000000001	3.4585352501167677
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.10163132000000001	3.4472293800664353
NON-DISTAL TRISOMY 13Q	0.1008403	3.4203987988615445
CONGENITAL TRACHEAL STENOSIS	0.10057470000000002	3.4113899212503367
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.100541419	3.410261064112615
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.100541419	3.410261064112615
LIPOID PROTEINOSIS	0.100541419	3.410261064112615
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.10023615000000001	3.399906655003066
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.3918966909673465
ELLIS VAN CREVELD SYNDROME	0.1	3.3918966909673465
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1	3.3918966909673465
METAPHYSEAL ANADYSPLASIA	0.1	3.3918966909673465
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	3.3918966909673465
LICHEN PLANUS PEMPHIGOIDES	0.1	3.3918966909673465
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	3.3918966909673465
KAPOSI SARCOMA	0.1	3.3918966909673465
LEISHMANIASIS	0.1	3.3918966909673465
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.1	3.3918966909673465
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	3.3918966909673465
JUVENILE XANTHOGRANULOMA	0.1	3.3918966909673465
AA AMYLOIDOSIS	0.1	3.3918966909673465
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.099348799	3.3698086257968005
WITTEVEEN-KOLK SYNDROME	0.099055293	3.359853205495009
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.356387060185477
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.3374178779412422
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.3281917832659436
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.3281917832659436
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.3281917832659436
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.3281917832659436
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.3281917832659436
49,XXXYY SYNDROME	0.09789425999999998	3.32047216558697
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.09752158	3.307831244999073
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.09728178	3.2996974767341336
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.09682066	3.2840567627127455
ROBERTS SYNDROME; RBS	0.09672797000000001	3.280912813669888
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09595502900000001	3.2546954534677575
TETRASOMY 9P	0.09483284300000003	3.2166320636672596
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.09361180000000001	3.1752155465549707
ROBERTS SYNDROME	0.09350383400000001	3.171553451373601
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.09325970400000001	3.1632728139819424
3P25.3 MICRODELETION SYNDROME	0.09257182000000001	3.1399404993482483
MONOSOMY 13Q34	0.09252355400000002	3.1383033664913866
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.09248751000000001	3.137080791248094
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.09199607300000001	3.120411755906905
CHARGE SYNDROME	0.091811704	3.1141581498967343
AICARDI SYNDROME	0.09146958999999998	3.102553996451398
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.0835427546881964
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09063464000000002	3.074233355030167
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.07002957394725
PSEUDOMYXOMA PERITONEI	0.09047619999999999	3.0688592339129976
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.090167594	3.058391637210872
MEIER-GORLIN SYNDROME 5; MGORS5	0.08993019	3.050339138790647
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08982882300000002	3.0469008748719153
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08979252999999998	3.0456698538058613
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.08962860300000002	3.0401096193172603
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08928740400000001	3.0285365017266463
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08925271000000001	3.0273597170886823
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08881885000000002	3.0126436341052516
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102000000001	3.007968582896091
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08867000000000001	3.0075947958807463
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.0075947958807463
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.08790998	2.981815702650056
22Q11.2 DELETION SYNDROME	0.08719101300000001	2.9574290847679094
ACROOTOOCULAR SYNDROME	0.08676967000000002	2.943137565493287
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	2.9323021515139915
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.9250512600387433
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08622765900000001	2.9247531123196073
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.086158213	2.922397575743598
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.08587826000000001	2.9129018592003346
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.08528754	2.8928652470674514
TRICHOHEPATOENTERIC SYNDROME 1	0.0840473	2.8507975875473988
WILLIAMS-BEUREN SYNDROME; WBS	0.08388099000000002	2.845156524160651
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.831163729227602
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	2.826579445173892
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	2.826579445173892
ALKAPTONURIA	0.08333330000000001	2.826579445173892
OROMANDIBULAR DYSTONIA	0.08333330000000001	2.826579445173892
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	2.826579445173892
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	2.826579445173892
SCLEROSTEOSIS	0.08333330000000001	2.826579445173892
DIPROSOPUS	0.08333330000000001	2.826579445173892
ERMINE PHENOTYPE	0.08333330000000001	2.826579445173892
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	2.826579445173892
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.082877923	2.8111335277794653
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.807465191508184
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.0822917	2.791249449240776
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.08223111	2.7891942990357186
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.08223111	2.7891942990357186
FRIEDREICH ATAXIA	0.08222186000000001	2.7888805485918047
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.786156652035156
PAPILLARY TUMOR OF THE PINEAL REGION	0.08184921	2.7762406455729147
PINEOCYTOMA	0.08184921	2.7762406455729147
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.08161245	2.76820999096738
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.7676520239617157
3MC SYNDROME 2	0.08095217400000002	2.745814111172129
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0807113	2.737643913936728
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.080673794	2.7363717491638133
NORMAL PRESSURE HYDROCEPHALUS	0.0803924	2.726827155389233
LOCKED-IN SYNDROME	0.08020053	2.720319123208274
3MC SYNDROME 3	0.07936511000000002	2.691982539872595
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0791926	2.686131178891007
PRIMARY PROGRESSIVE FREEZING GAIT	0.07910191000000001	2.683055067781969
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.07852351	2.6634363373214134
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.077850554	2.640610365025747
N SYNDROME	0.07746865400000001	2.6276567115629432
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.6276567115629432
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.6275164566347717
DDOST-CDG	0.07746451900000001	2.6275164566347717
NEUROFIBROMATOSIS TYPE 1	0.07746451900000001	2.6275164566347717
7Q11.23 MICRODUPLICATION SYNDROME	0.077365189	2.6241472856516337
OKAMOTO SYNDROME	0.076983234	2.611191766645649
DERMATOMYOSITIS	0.07692310000000001	2.6091520834895032
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.6091520834895032
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.6091520834895032
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.6091520834895032
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.6091520834895032
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.6091520834895032
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.6091520834895032
DERMOODONTODYSPLASIA	0.07692310000000001	2.6091520834895032
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.6091520834895032
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07689308	2.6081338361028745
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.076616449	2.5987507983676843
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.5883258378069636
NOONAN SYNDROME 7; NS7	0.07567976900000001	2.566979580442732
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0754241	2.558307552091902
URBAN-ROGERS-MEYER SYNDROME	0.07502633	2.5448156046242416
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07489701900000001	2.5404295090941846
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.07462507	2.531205279962066
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.07442027300000001	2.524258777295866
COHEN SYNDROME	0.074356663	2.522101191810741
MIYOSHI MYOPATHY	0.07404541	2.5115438116032047
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07394574999999999	2.508163447360986
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.07394574999999999	2.508163447360986
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07394574999999999	2.508163447360986
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.5025936138047493
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.07356325	2.4951894425180363
MYOPATHY AND DIABETES MELLITUS	0.07356325	2.4951894425180363
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.073394869	2.4894781329508184
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.4596533210230107
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.4596533210230107
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.4596533210230107
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.4596533210230107
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.072426573	2.4566345329680495
CRANIOECTODERMAL DYSPLASIA 1	0.07231183999999999	2.4527429081376018
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.441288947877742
RABIES	0.07197001900000001	2.4411486929495707
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.4411486929495707
VASCULAR EHLERS-DANLOS SYNDROME	0.07194529399999999	2.4403100464927285
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.422784319804302
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.422784319804302
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.422784319804302
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.422784319804302
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.422784319804302
ESOPHAGEAL ATRESIA	0.07142860000000001	2.422784319804302
3MC SYNDROME 1	0.07142860000000001	2.422784319804302
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.07133404	2.419576942293323
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.07110015	2.41164363512282
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.07038685400000001	2.3874493717020178
JACOBSEN SYNDROME	0.070235983	2.382331983245388
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.07019710000000001	2.3810131120550393
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.07019710000000001	2.3810131120550393
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.07019710000000001	2.3810131120550393
2Q23.1 MICRODUPLICATION SYNDROME	0.070081994	2.377108835449934
PHAVER SYNDROME	0.06957387000000001	2.3598737943079238
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.359579513351015
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.3569509969293168
SPONDYLO-OCULAR SYNDROME	0.0694118	2.3543765473408724
HOLMES-GANG SYNDROME	0.06909417400000001	2.343603001557221
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.06902777	2.3413506464785505
EPISODIC ATAXIA TYPE 1	0.06901964	2.3410748852775747
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.068952349	2.338792444075256
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.330771659889092
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.330771659889092
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06863134	2.3279041504265487
YOU-HOOVER-FONG SYNDROME; YHFS	0.06851795399999999	2.3240582144445283
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.068270473	2.3156639145947557
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.068177764	2.3125193210915267
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.06813294900000001	2.31099924258947
TRISOMY 20P	0.06779684	2.299598772540426
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.298033751407214
KLEEFSTRA SYNDROME	0.06759917300000001	2.2928941121082924
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.289298939048635
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.06734	2.284103231697411
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.067208119	2.279629964422396
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.279629964422396
PEHO SYNDROME	0.06707321399999999	2.2750541261914465
RING CHROMOSOME 10 SYNDROME	0.067056209	2.274477334159148
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.2612655912771276
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	2.2612655912771276
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.2612655912771276
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771276
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	2.2612655912771276
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.2612655912771276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	2.2612655912771276
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.2612655912771276
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771276
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.2612655912771276
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.2612655912771276
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0666667	2.2612655912771276
DESMOID TUMOR	0.0666667	2.2612655912771276
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06653733399999999	2.2568776302038907
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.06609733000000001	2.2419531490877675
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.06583433400000001	2.233032596466391
SMITH-MAGENIS SYNDROME; SMS	0.065329293	2.2159021274993624
BECKER MUSCULAR DYSTROPHY	0.06504991	2.2064257447672366
MENTAL RETARDATION, X-LINKED 98; MRX98	0.06490376299999999	2.2014685895102883
CRYPTOCOCCOSIS	0.06486894900000001	2.2002877345962957
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.198451056457104
FG SYNDROME TYPE 1	0.064568243	2.190088097732755
PERLMAN SYNDROME	0.064564384	2.189957204439451
DESMOSTEROLOSIS	0.06439297	2.184143018645596
ANGELMAN SYNDROME	0.06432941299999999	2.1819872308657176
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.06402941000000001	2.1718114390359156
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.06283113	2.1311670193673917
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898	2.1222751621920204
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.062373160000000004	2.1156331500917687
WILLIAMS SYNDROME	0.06234121000000001	2.1145494390990045
AARSKOG-SCOTT SYNDROME	0.061731544	2.0938701982190513
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.061666143	2.091651863864192
DOORS SYNDROME	0.06152097399999999	2.0867278813568815
AMISH INFANTILE EPILEPSY SYNDROME	0.061147400000000005	2.0740566372125673
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109523	2.0722870847088894
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.060881260000000006	2.065029443359227
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.060869104	2.064617124397473
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.060702009999999994	2.0589494685406677
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.05952815	2.0191333500440787
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05949911	2.0181483432450213
HYPERTELORISM, TEEBI TYPE	0.058779000000000005	1.9937229559836966
VELOCARDIOFACIAL SYNDROME	0.05874286999999999	1.9924974637092494
7P22.1 MICRODUPLICATION SYNDROME	0.058454094000000005	1.9827024801209423
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.05811118300000001	1.9710712932589796
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.964197852047502
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.057803064	1.9606202150937373
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	1.9597670174000916
NORRIE DISEASE	0.05774132900000001	1.9585262276715691
17Q21.31 MICRODUPLICATION SYNDROME	0.057732474	1.9582258752195836
CHIME SYNDROME	0.057728339000000004	1.958085620291412
YUNIS-VARON SYNDROME	0.057407410000000006	1.9472000401600575
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.9456139892673612
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.944554021551434
ALPHA-MANNOSIDOSIS	0.057316824	1.9441274566235778
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.05728379	1.9430069774706837
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.05728379	1.9430069774706837
SIMPSON-GOLABI-BEHMEL SYNDROME	0.056942483	1.9314301966316438
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.056869403000000006	1.9289513985298852
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.056757249	1.9251472507150973
OGDEN SYNDROME	0.056591434	1.9195229772169697
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.9179072811471944
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056485419	1.915927057940041
MICROHYDRANENCEPHALY; MHAC	0.05646882	1.9153640370083072
MONOSOMY 13Q14	0.05631795	1.9102466824706443
ATELOSTEOGENESIS TYPE II	0.056312100000000004	1.910048256514223
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.056218954	1.9068888404224544
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.05621583	1.9067828775698288
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.902752931192324
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.05572271	1.8900567566073305
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.055605724	1.8860887123444354
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.8843885580470552
GITELMAN SYNDROME	0.055555600000000004	1.8843885580470552
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.8843885580470552
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.8843885580470552
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.8843885580470552
WILDERVANCK SYNDROME	0.055555600000000004	1.8843885580470552
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.8843885580470552
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.8843885580470552
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.8843885580470552
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8843885580470552
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.8843885580470552
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.8843885580470552
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.8843885580470552
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.8843885580470552
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.8843885580470552
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.055471664	1.8815415356405247
PURE MITOCHONDRIAL MYOPATHY	0.05544662	1.880692069033239
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872623999999995	1.8612227177029539
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05468078	1.8547155674151345
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.05459519399999999	1.851812578713203
SIFRIM-HITZ-WEISS SYNDROME	0.05458702000000001	1.8515353250776838
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.054524842999999996	1.8494263454721407
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	1.8405421879022583
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.05416457	1.8372062575066919
3Q27.3 MICRODELETION SYNDROME	0.05415799	1.8369830707044263
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.054135264	1.8362122282624374
TRICHOTHIODYSTROPHY	0.054080064	1.8343399012890231
HOLOPROSENCEPHALY	0.05389250299999999	1.8279780259364775
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.053721054000000004	1.8221626529787815
SLC39A8-CDG	0.05356896900000001	1.8170040868963238
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.053478300000000006	1.8139286880855907
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.053441419000000004	1.8126777226669948
MONOSOMY 18P	0.053423134	1.8120575143570512
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.053292754	1.807635159451368
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05320941900000001	1.8048085223439507
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.052804109	1.791060825865791
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.7852094988031697
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.7852094988031697
PENILE AGENESIS	0.0526316	1.7852094988031697
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.05260885900000001	1.7844381475766773
CARDIOFACIOCUTANEOUS SYNDROME	0.052239054	1.7718947440186452
SILVER-RUSSELL SYNDROME; SRS	0.051868254	1.7593175910885384
DIASTROPHIC DWARFISM	0.0518518	1.7587594884070066
20P12.3 MICRODELETION SYNDROME	0.051807133	1.757244429912052
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.051678879999999996	1.7528942206489855
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0515873	1.749787921659398
PITT-HOPKINS SYNDROME	0.051423513	1.7442324358261632
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.7360106817610597
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.050919583000000004	1.7271396508313714
LISSENCEPHALY, X-LINKED, 2	0.05083609900000001	1.7243079597978845
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.7229381084002702
GIANT AXONAL NEUROPATHY	0.05044494	1.7110402506204634
HISTIDINEMIA	0.05043863	1.7108262219392631
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.05029260399999999	1.705873170877311
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.05025664900000001	1.704653614422074
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.05	1.6959483454836732
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.049920694	1.6932583678939346
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704000000004	1.6866784275031272
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.04941234	1.6760155253895344
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.049404979999999994	1.6757658817930792
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.6646361868568758
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970854	1.6610407763644504
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.048899293	1.658613501173427
MEHMO SYNDROME	0.048657729000000004	1.650419899850859
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.048606510000000006	1.6486826042847125
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.04840441	1.6418275810722673
DESMINOPATHY	0.04840441	1.6418275810722673
OCULOPHARYNGODISTAL MYOPATHY	0.04840441	1.6418275810722673
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.048388444	1.6412860308465875
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.04835373900000001	1.6401088730999873
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04835373900000001	1.6401088730999873
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.048330040000000005	1.639305027503195
XP22.13P22.2 DUPLICATION SYNDROME	0.04828666899999999	1.6378339279893552
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.04826488	1.6370948676193608
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6296038637773593
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.04800712900000001	1.6283522199794256
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.04774224	1.6193674587536888
ANOPHTHALMIA PLUS SYNDROME	0.047619	1.6151872852717408
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.04761567900000001	1.6150746403826337
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.04757592	1.613726056177272
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.04753696	1.6124045732264711
ACROCEPHALOPOLYDACTYLY	0.04746115	1.6098331763450486
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.047402563999999994	1.6078459997496783
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.047402563999999994	1.6078459997496783
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0473363	1.6055983933263758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.047316830000000004	1.6049379910406447
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.04723343000000001	1.6021091492003778
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04721556999999999	1.6015033564513708
OCULODENTODIGITAL DYSPLASIA; ODDD	0.047146249	1.5991520597462254
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.04691821300000001	1.5914173142080115
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.04685700999999999	1.5893413716762383
DUPLICATION/INVERSION 15Q11	0.046824869000000005	1.588251182160795
WOLF-HIRSCHHORN SYNDROME	0.046767933	1.5863199718608254
16P13.11 MICRODELETION SYNDROME	0.046763204	1.58615956906631
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.585567208228199
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.5842789658649696
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.046659059999999995	1.5826271121764686
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.046376794000000006	1.5730529410627432
JUVENILE PRIMARY LATERAL SCLEROSIS	0.04635260000000001	1.5722323055773306
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.046340780000000005	1.571831383388458
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349	1.568560543490391
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.5637662671125434
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04601606900000001	1.560817521724251
FRYNS SYNDROME; FRNS	0.045984359	1.5597419512835453
HUNTINGTON DISEASE	0.045702929999999996	1.5501961703451224
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.045662519	1.5488254709733358
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.045382349	1.5393223940142526
MOHR-TRANEBJAERG SYNDROME	0.045358050000000004	1.5384981970373146
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.535964450209162
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.045158184000000004	1.5317189487969458
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.045083864	1.5291980911762186
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.045032824	1.5274668671051488
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.523826887090204
MEHMO SYNDROME; MEHMO	0.044836343	1.5208024345677693
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.044653293999999996	1.5145936015939205
DIENCEPHALIC SYNDROME	0.044614259999999996	1.5132696086395683
ZELLWEGER SYNDROME	0.04452457900000001	1.5102277217681421
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.5075084721099605
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.044431554	1.5070724098713695
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.044316049999999996	1.5031546335174344
DE BARSY SYNDROME	0.044291424	1.5023193450383172
PGM3-CDG	0.04425729899999999	1.501161860292524
OCULODENTODIGITAL DYSPLASIA	0.044201799	1.4992793576290375
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.4989547531157121
OCULO-PALATO-CEREBRAL SYNDROME	0.044129784	1.4968366832270374
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.044081028999999994	1.495182963995356
COG1-CDG	0.04404964	1.4941182815430287
AICARDI-GOUTIERES SYNDROME 6	0.044023854	1.4932436470622958
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.4931033921341244
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.4931033921341244
6P22 MICRODELETION SYNDROME	0.04395932	1.491054720451747
NOONAN SYNDROME	0.04385423	1.4874901762192094
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.043850780000000006	1.4873731557833711
HAMAMY SYNDROME; HMMS	0.04363133999999999	1.479929977684712
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.043589710000000004	1.4785179310922625
SWEENEY-COX SYNDROME; SWCOS	0.043589244	1.4785021248536825
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.043478300000000004	1.4747390189888558
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.4747390189888558
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.4747390189888558
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.043478300000000004	1.4747390189888558
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.043443123	1.4735458514898743
OSGOOD-SCHLATTER DISEASE	0.04338761	1.4716629078798176
X-LINKED DYSTONIA-PARKINSONISM	0.04338761	1.4716629078798176
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.04330362900000001	1.4688143591197764
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.467619868781085
PROGRESSIVE SUPRANUCLEAR PALSY	0.04281613	1.4522788966702773
LISSENCEPHALY 2; LIS2	0.042790883999999994	1.4514225784316754
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.450258004621799
ALG13-CDG	0.0426748	1.447485129076933
WEST SYNDROME	0.0426748	1.447485129076933
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256882	1.443890396963846
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.042525434	1.4424187886655029
HUNTINGTON DISEASE-LIKE 3	0.042472318999999994	1.4406171827380954
COG2-CDG	0.04221225399999999	1.431796046608731
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.4316557916805595
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.4316557916805595
SARCOSINEMIA	0.042198844	1.4313411932624724
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.4302003627294326
SHPRINTZEN OMPHALOCELE SYNDROME	0.042057460000000005	1.4265455940449154
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904994	1.421374104836065
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.4132914185352912
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.4132914185352912
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.4132914185352912
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.041589882999999994	1.4106858652541907
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.410060603018178
MERRF	0.041517359999999996	1.4082259600170006
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.041474173	1.4067611015930725
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.04144528	1.4057810808821514
RICHIERI COSTA-DA SILVA SYNDROME	0.04137935	1.4035448033937967
15Q13.3 MICRODELETION SYNDROME	0.041349853	1.402544295626862
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.041266000000000004	1.3997000884945854
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.04122263	1.3982290228997127
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.041205410000000005	1.3976449382895282
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.041188763	1.3970802892473828
MASA SYNDROME	0.041164200000000005	1.3962471376631806
PARKINSONIAN-PYRAMIDAL SYNDROME	0.041164200000000005	1.3962471376631806
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.04107905	1.3933589376308217
TOWNES-BROCKS SYNDROME 2; TBS2	0.04107905	1.3933589376308217
QAZI-MARKOUIZOS SYNDROME	0.041044329000000004	1.3921812371807512
LESCH-NYHAN SYNDROME	0.041030029999999995	1.3916962298729094
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.3916962298729094
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.040989269999999994	1.390313692781671
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.3882564735196328
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.040928619000000006	1.3882564735196328
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.040908053	1.3875588960461682
SPINOCEREBELLAR ATAXIA TYPE 11	0.04064041	1.3784807219855626
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.3752633044603784
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.0405388	1.3750342157578705
MAL DE MELEDA	0.04051068	1.3740804144083705
GERODERMA OSTEODYSPLASTICA	0.040484054	1.3731772879954334
SHORT RIB-POLYDACTYLY SYNDROME	0.040389549999999996	1.3699718099466016
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3671043004840582
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.365799777016712
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040206928999999995	1.3637774942905903
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.04018249	1.3629485486582849
9P13 MICRODELETION SYNDROME	0.04012756	1.3610853798059364
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.040113833	1.3606197741471675
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0399385	1.3546726599219936
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03974616	1.348148685826587
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.039741824	1.3480016131860668
BRACHYDACTYLY TYPE A4	0.0397397	1.3479295693003506
WAISMAN SYNDROME; WSMN	0.039548473	1.3414433470151144
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.03940891	1.3367095142362995
CHAR SYNDROME	0.039387604	1.335986836727322
MONOSOMY 9P	0.039254292999999996	1.3314650653296265
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039177794	1.3288702982800038
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.326928301748557
DUBOWITZ SYNDROME	0.039098199	1.326170518108828
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.3257628460455406
OTOFACIOCERVICAL SYNDROME	0.03900606399999999	1.323045394092605
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.039002919000000004	1.3229387189416746
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.038978482999999994	1.3221098750662694
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.038742149999999996	1.3140937038596057
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.038742149999999996	1.3140937038596057
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.038632240000000005	1.3103656702065636
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.3094062383085563
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.3091091081584278
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.03855063300000001	1.3075976450739661
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3066027000176041
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3045743457964059
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0384615	1.3045743457964059
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0384615	1.3045743457964059
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3045743457964059
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3045743457964059
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.0384615	1.3045743457964059
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3045743457964059
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0384615	1.3045743457964059
CYCLIC NEUTROPENIA	0.0384615	1.3045743457964059
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3045743457964059
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0384615	1.3045743457964059
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3045743457964059
SPASTIC PARAPLEGIA 16, X-LINKED	0.0384615	1.3045743457964059
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3045743457964059
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0384615	1.3045743457964059
BAZEX SYNDROME; BZX	0.0384615	1.3045743457964059
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3045743457964059
LIP, HAMARTOMATOUS	0.0384615	1.3045743457964059
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3045743457964059
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3045743457964059
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3045743457964059
MOSAIC TRISOMY 8	0.038460509999999996	1.3045407660191652
TEMPLE-BARAITSER SYNDROME	0.038439229000000005	1.3038189364843606
BARDET-BIEDL SYNDROME 1; BBS1	0.038309034	1.2994028565875555
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.038263999	1.2978753159127785
RETT SYNDROME	0.038210349	1.2960555633380744
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.038207	1.295941968717894
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.038109669	1.2926406017496086
DISTAL TRISOMY 5Q	0.03808761	1.2918923832585483
BAKER-GORDON SYNDROME; BAGOS	0.038032024000000005	1.290006963563907
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.03793677399999999	1.2867761819657604
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.2849610423705562
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.037708754	1.2790419791310168
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.274761405507016
JAWAD SYNDROME	0.037582554	1.274761405507016
ISOTRETINOIN-LIKE SYNDROME	0.03757725	1.2745814993065272
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037521043999999996	1.272675049852402
FLYNN-AIRD SYNDROME	0.037472419	1.271025740086419
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.037422679	1.2693386106723321
BRAIN-LUNG-THYROID SYNDROME	0.037381293999999995	1.267934874226775
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294	1.2588445910949826
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.256256777433576
CLEIDORHIZOMELIC SYNDROME	0.037037	1.256256777433576
BRACHYDACTYLY, TYPE A1, D	0.037037	1.256256777433576
BRACHYDACTYLY, TYPE A4	0.037037	1.256256777433576
MYOCLONUS AND ATAXIA	0.037037	1.256256777433576
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	1.256256777433576
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	1.256256777433576
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.256256777433576
CANAVAN DISEASE	0.037037	1.256256777433576
MCLEOD SYNDROME; MCLDS	0.037037	1.256256777433576
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.256256777433576
BRACHYDACTYLY, TYPE A3	0.037037	1.256256777433576
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.256256777433576
SYNPOLYDACTYLY 1	0.037037	1.256256777433576
CLEIDORHIZOMELIC SYNDROME	0.037037	1.256256777433576
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2526613669411506
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.036917530000000004	1.2522044784568775
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.03683574	1.2494302461533353
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2482611611208596
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.036801273	1.2482611611208596
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.036780129999999994	1.247544012403488
HAREL-YOON SYNDROME; HAYOS	0.036653204	1.243238813609511
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388	1.234243367909198
PITT-HOPKINS SYNDROME	0.036157179	1.2264141580481402
THUMBS, CONGENITAL CLASPED	0.0361093	1.2247901518314719
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.036090284	1.2241451487567176
PHELAN-MCDERMID SYNDROME	0.036045813	1.2226367383792778
MICROPHTHALMIA WITH LIMB ANOMALIES	0.036036000000000006	1.222303891556993
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.035932563	1.218795415376757
CHROMOSOME 17Q12 DELETION SYNDROME	0.03592785	1.2186355552857118
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035920563	1.218388387773841
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.035884189999999996	1.2171546531904351
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.035770528999999995	1.2132993894925148
VESTIBULOPATHY, FAMILIAL	0.035714300000000004	1.211392159902151
MALARIA	0.035714300000000004	1.211392159902151
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.035714300000000004	1.211392159902151
YOUNG-ONSET PARKINSON DISEASE	0.035714300000000004	1.211392159902151
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.035714300000000004	1.211392159902151
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.211392159902151
SPINOCEREBELLAR ATAXIA TYPE 1	0.035714300000000004	1.211392159902151
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.03543121	1.2017900395596914
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.1995647518166155
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.03529794	1.1972696588396394
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748734
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748734
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.035256380000000004	1.1958599865748734
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748734
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748734
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.035229109999999994	1.1949350163472463
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.1926434170238622
NEMALINE MYOPATHY 2; NEM2	0.034993869999999996	1.1869559185714147
COSTELLO SYNDROME	0.03496462	1.185963788789307
MARSHALL-SMITH SYNDROME; MRSHSS	0.03485368	1.1822008186003476
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034617714	1.1741970956545398
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	1.1696209521528882
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	1.1696209521528882
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	1.1696209521528882
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	1.1696209521528882
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	1.1696209521528882
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	1.1696209521528882
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.034446634000000004	1.168394238795633
SIALIDOSIS TYPE 1	0.034436739	1.1680586106180617
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.167979613344129
ZUNICH NEUROECTODERMAL SYNDROME	0.034283779	1.162870365439558
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.1607999856183584
SCHWARTZ-JAMPEL SYNDROME	0.034151310000000004	1.1583771538120007
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.033974330000000004	1.1523741750483267
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03394403	1.1513464303509633
FETAL HYDANTOIN SYNDROME	0.033922884	1.1506291798766914
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.033878854	1.1491357277636585
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.033878854	1.1491357277636585
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.033874719000000005	1.1489954728354872
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.033874719000000005	1.1489954728354872
KOOLEN-DE VRIES SYNDROME	0.033874243	1.148979327407238
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774000000006	1.1474370659008222
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.03379519	1.1462979313161277
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.033624523	1.1405090829905544
TRISOMY 12P	0.033553313999999994	1.1380937472758832
H SYNDROME	0.033518240000000005	1.1369040734304936
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.033353173	1.1313051713196143
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.131030427687646
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.0333333	1.1306310996902185
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03326377	1.1282727139209887
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.033249464	1.127787469180379
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.1245358613365501
PEHO-LIKE SYNDROME; PEHOL	0.033016444	1.119883671511087
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.033002519	1.1194113498968699
TRISOMY 4P	0.032996029999999996	1.1191912497205927
FRYNS MICROPHTHALMIA SYNDROME	0.032996029999999996	1.1191912497205927
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1169081640579028
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.032920050000000006	1.116614086614796
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03290601	1.116137864319384
FOUNTAIN SYNDROME	0.032889259	1.1155696877046801
MUCOLIPIDOSIS TYPE II	0.03284823	1.1141780264113432
CHILDHOOD APRAXIA OF SPEECH	0.0328042	1.1126845742983102
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.1126660545423774
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.1126660545423774
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.1126660545423774
LEIGH SYNDROME	0.032799519	1.1125257996142062
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.1125257996142062
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.1125257996142062
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.1125257996142062
SANDHOFF DISEASE	0.032799519	1.1125257996142062
TUBEROUS SCLEROSIS-1	0.032799519	1.1125257996142062
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.1125257996142062
MENINGIOMA	0.03270391	1.109282841106939
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.032655939999999994	1.107655748264282
PITT-HOPKINS-LIKE SYNDROME	0.032651229000000004	1.1074959560111708
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.032522234	1.1031205788746572
15Q24 MICRODELETION SYNDROME	0.032521943	1.1031107084552865
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.032520634	1.1030663085276016
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032337370000000004	1.0968501829758674
ALLAN-HERNDON-DUDLEY SYNDROME	0.03228124	1.0949463113632274
DYSTONIA, JUVENILE-ONSET	0.0322581	1.0941614264689374
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.0941614264689374
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.0941614264689374
DENT DISEASE	0.0322581	1.0941614264689374
CONGENITAL ANALBUMINEMIA	0.0322581	1.0941614264689374
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.0941614264689374
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.0941614264689374
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.0941614264689374
MILD CANAVAN DISEASE	0.0322581	1.0941614264689374
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.0941614264689374
SECKEL SYNDROME 2; SCKL2	0.0322581	1.0941614264689374
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.0941614264689374
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.0941614264689374
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.0941614264689374
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.032220603	1.0928895669667256
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.032140369	1.0901681125756948
TONNE-KALSCHEUER SYNDROME; TOKAS	0.031972584	1.084477018712755
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.031949474	1.0836931513874726
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.08238815305459
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.03188151	1.0813878827204237
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031858759	1.0806161923042616
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.031762403999999994	1.0773479302476798
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.031525183	1.0693016389984003
21Q22.11Q22.12 MICRODELETION SYNDROME	0.031407909	1.0653238260730353
NARP SYNDROME	0.031389972999999995	1.0647154554825433
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0646064399228958
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031368354	1.0639821613369234
COFFIN-LOWRY SYNDROME	0.031275709	1.0608397386475765
11Q22.2Q22.3 MICRODELETION SYNDROME	0.031248273000000003	1.0599091378714427
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.03122715	1.0591926675334096
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.03118225	1.0576697059191655
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.030989753000000005	1.051140406545954
XQ28 (MECP2) DUPLICATION	0.030981663000000003	1.0508660021036547
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.030848553999999997	1.0463510823372748
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.0462108274091033
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.030844418999999998	1.0462108274091033
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.030824463000000003	1.0455339405054542
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.030677728999999997	1.0405568748149299
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.030567110000000005	1.036804792614349
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.030498773	1.0344868721726426
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.030447213000000004	1.0327380102387798
RENPENNING SYNDROME 1; RENS1	0.030427489000000002	1.0320689925354534
LATHOSTEROLOSIS	0.030361083	1.0298165696188495
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.030309789	1.0280767301301847
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.030302999999999997	1.0278464542638348
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.030302999999999997	1.0278464542638348
MACHADO-JOSEPH DISEASE TYPE 3	0.030302999999999997	1.0278464542638348
MACHADO-JOSEPH DISEASE TYPE 2	0.030302999999999997	1.0278464542638348
MACHADO-JOSEPH DISEASE TYPE 1	0.030302999999999997	1.0278464542638348
CARIBBEAN PARKINSONISM	0.030302999999999997	1.0278464542638348
SPINOCEREBELLAR ATAXIA TYPE 26	0.030302999999999997	1.0278464542638348
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.030302999999999997	1.0278464542638348
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.0278464542638348
SPINOCEREBELLAR ATAXIA 18	0.030302999999999997	1.0278464542638348
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.0278464542638348
FREEMAN-SHELDON SYNDROME	0.03028189	1.0271304248723716
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0220035730239747
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.016122499027374
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.029957354	1.016122499027374
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254	1.0152032950241217
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.029914163000000004	1.0146575049275786
MYOPATHY, DISTAL 3	0.0299107	1.01454004354517
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0077655100412015
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.029663389999999998	1.0061515438387387
EAR WAX, WET/DRY	0.0294118	0.997617870953934
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.997617870953934
ALKAPTONURIA	0.0294118	0.997617870953934
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.997617870953934
OSSIFIED EAR CARTILAGES	0.0294118	0.997617870953934
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.997617870953934
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.997617870953934
EAR FOLDING	0.0294118	0.997617870953934
EAR MALFORMATION	0.0294118	0.997617870953934
BLAU SYNDROME	0.0294118	0.997617870953934
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.997617870953934
AREDYLD	0.0294118	0.997617870953934
DARWINIAN POINT OF PINNA	0.0294118	0.997617870953934
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	0.997617870953934
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.997617870953934
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0294118	0.997617870953934
OSTEOMA OF MIDDLE EAR	0.0294118	0.997617870953934
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.997617870953934
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0294118	0.997617870953934
EAR WITHOUT HELIX	0.0294118	0.997617870953934
MUSICAL PERFECT PITCH	0.0294118	0.997617870953934
HAIRY EARS, Y-LINKED	0.0294118	0.997617870953934
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.029353104	0.9956269632722038
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301533	0.993877728229705
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029202049000000004	0.9905033337256631
ACROCALLOSAL SYNDROME; ACLS	0.029130189000000004	0.9880659167635342
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.029080913000000007	0.9863945257500931
SCHAAF-YANG SYNDROME; SHFYNG	0.028961273000000003	0.9823364605490196
GABRIELE-DE VRIES SYNDROME	0.02882784	0.977810551037361
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.028827190000000003	0.9777885037088698
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02880755	0.9771223351987638
SHUKLA-VERNON SYNDROME; SHUVER	0.028805623000000002	0.9770569733495289
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9708965088224931
DYSTONIA 28, CHILDHOOD-ONSET	0.028539494000000006	0.9680301526048245
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.028535359000000007	0.967889897676653
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	0.9677031737638151
CHROMOSOME 18Q DELETION SYNDROME	0.028519059000000003	0.9673370185160253
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.028400223000000006	0.9633062241643474
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.028400223000000002	0.9633062241643472
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.028360993	0.9619755830924807
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341363999999997	0.9613097876910106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.028340654	0.961285705224505
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9606989070969676
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9606989070969676
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9606989070969676
MENKES DISEASE	0.028319219000000003	0.9605586521687961
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.028143519999999998	0.9545991236017333
HENNEKAM SYNDROME	0.028131819000000002	0.9542022377699234
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.028063704000000002	0.9518918473388708
CAP MYOPATHY	0.027993940000000005	0.9495255245313845
DISTAL MONOSOMY 7Q36	0.027935149	0.9475313945477978
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9421942790235276
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9421942790235276
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9421942790235276
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9421942790235276
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9421942790235276
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9421942790235276
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9421942790235276
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9421942790235276
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9421942790235276
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9421942790235276
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9421942790235276
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9421942790235276
DWARFISM, LEVI TYPE	0.027777800000000002	0.9421942790235276
CLEFT CHIN	0.027777800000000002	0.9421942790235276
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9421942790235276
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9421942790235276
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9421942790235276
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9421942790235276
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9421942790235276
OROFACIAL CLEFT 3	0.027777800000000002	0.9421942790235276
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9421942790235276
DIMPLES, FACIAL	0.027777800000000002	0.9421942790235276
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9421942790235276
GANGLIOCYTOMA	0.027777800000000002	0.9421942790235276
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9421942790235276
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9421942790235276
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9421942790235276
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.027743873000000002	0.941043510233183
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.02759332	0.935936908008031
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9352325467411847
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.027563409000000004	0.9349223577887958
DISTAL MONOSOMY 10Q	0.027543303	0.9342403830401099
BRITTLE CORNEA SYNDROME	0.027257780000000002	0.9245557378511592
MUCOPOLYSACCHARIDOSIS TYPE 4	0.027257780000000002	0.9245557378511592
CEREBROFACIOTHORACIC DYSPLASIA	0.027245870000000002	0.9241517629552649
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.027197913000000004	0.9225251110591779
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9198993420737991
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9167279186677446
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9167279186677446
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9167279186677446
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354	0.9167060070151211
MELAS	0.02688837	0.9120257322850567
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.026885169	0.9119171576719789
INFANTILE SIALIC ACID STORAGE DISEASE	0.026712733000000002	0.9060683066939424
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.026701364	0.9056826819591463
KEPPEN-LUBINSKY SYNDROME	0.026586139	0.9017743689969792
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.026484563000000003	0.8983290160141622
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.8967921815424517
SECKEL SYNDROME 1; SCKL1	0.026411979	0.8958670417199903
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.026336443999999997	0.8933049725544682
HURLER SYNDROME	0.026319694	0.8927368298587313
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.026186554000000004	0.8882208586043774
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.02616939	0.8876386734563396
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.026167179	0.8875636786205022
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026162674	0.8874108736745743
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.026162440000000002	0.8874029366363174
AL KAISSI SYNDROME; ALKAS	0.026052393	0.8836702560848085
COFS SYNDROME	0.026042469	0.883333644257197
AYMÉ-GRIPP SYNDROME	0.026041254	0.8832924327124018
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.02601911	0.882541331109154
CRANIOFACIAL DYSSYNOSTOSIS	0.02601049	0.8822489496143926
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.025913600000000002	0.8789625409105143
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.025818759000000004	0.875745632169834
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.025776010000000002	0.8742956302534124
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.025641000000000004	0.8697162305309375
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.025641000000000004	0.8697162305309375
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.025641000000000004	0.8697162305309375
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0256073	0.8685731613460812
VERVERI-BRADY SYNDROME; VERBRAS	0.02557473	0.8674684205938332
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.025553933	0.8667630078390127
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513389	0.865387797244627
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0254947	0.864753885672052
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02544385	0.8630291062046951
19P13.3 MICRODUPLICATION SYNDROME	0.025352614	0.8599344753397242
FRANK-TER HAAR SYNDROME	0.02526559	0.8569827111633769
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8563845162629579
SPINOCEREBELLAR ATAXIA TYPE 40	0.02508944	0.8510078851422378
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.02497197	0.8470234240993585
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8470234240993585
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954454000000004	0.8464292994749687
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.024924	0.8453963312567014
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.024924	0.8453963312567014
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.024878618999999998	0.8438570546193733
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.024875134	0.8437388470196933
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.024755060000000002	0.8396660609869813
2P15P16.1 MICRODELETION SYNDROME	0.024740554	0.8391740324529894
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.02467052	0.8367985515244375
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.024621134	0.8351234294246362
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.024563314000000003	0.833162234757919
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02455864	0.8330036975065831
RETT SYNDROME, CONGENITAL VARIANT	0.024555659	0.8329025850662255
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.024525190000000002	0.8318691080634546
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0243656	0.8264559801343397
ASPARTYLGLUCOSAMINURIA; AGU	0.024350919000000002	0.8259580157811389
CLASSIC HOMOCYSTINURIA	0.024350919000000002	0.8259580157811389
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0243372	0.825492681474105
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0242857	0.8237458546782569
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0242857	0.8237458546782569
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.02425478	0.8226970802214097
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228373	0.8218013820622261
TRISOMY 18P	0.024186850000000003	0.8203929647992356
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.024164763000000002	0.8196437965771017
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024151954	0.8192093285299555
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.023949163000000002	0.8123308673113762
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.023925473000000003	0.811527326985286
OCULOCEREBRORENAL SYNDROME OF LOWE	0.023880869	0.8100144053852467
WEAVER SYNDROME	0.023855703000000002	0.8091608006639981
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.8075936426358704
HURLER-SCHEIE SYNDROME	0.0238095	0.8075936426358704
SCIMITAR SYNDROME	0.0238095	0.8075936426358704
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.8075936426358704
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023802843	0.8073678440731527
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.023799364	0.8072498399872738
OHDO SYNDROME	0.023742229	0.8053118798128897
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.023667754	0.8027857647522917
CHROMOSOME 10Q26 DELETION SYNDROME	0.023580363	0.7998215523150884
ADAMS-OLIVER SYNDROME	0.023392499	0.7934493995155697
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.023326333	0.7912051171510242
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.02325381	0.788745211913834
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.023242132999999998	0.7883491401372296
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.023207859000000004	0.7871866014653676
BARAITSER-WINTER SYNDROME 1; BRWS1	0.023201433	0.7869686381840059
COCKAYNE SYNDROME	0.023084249	0.7829938779656628
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.023059784	0.7821640504402175
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.023053753000000003	0.7819594851507855
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02304886	0.7817935196456963
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022948299	0.7783825944142926
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.022904050000000002	0.7768817140475065
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.022811754	0.7737511290776112
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.022808529	0.7736417404093276
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.022744554	0.7714717745012812
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02271952	0.7706226470836643
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.767490230489556
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.7672141300989114
DYSTONIA 12; DYT12	0.02261903	0.7672141300989114
BRANCHIOOTORENAL SYNDROME 1	0.02256055	0.7652305489140335
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.02253232	0.7642730164781736
JOUBERT SYNDROME 3; JBTS3	0.02252453	0.7640087877259473
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.7636246215067282
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7621771635128248
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7621771635128248
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.7617031120312953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7617031120312953
MYHRE SYNDROME	0.022435563000000002	0.7609911189968944
GLASS SYNDROME	0.022430952999999997	0.7608347525594407
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883	0.7596791333568281
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02231618	0.7569417709703168
RAPID-ONSET DYSTONIA-PARKINSONISM	0.022308269000000002	0.7566734380230944
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.022266243	0.7552479595197484
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0222662	0.7552465010041712
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02226572	0.7552302199000547
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.022182923000000004	0.7524218311968345
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02216733	0.7518929327458118
SMITH-MAGENIS SYNDROME	0.022150542999999998	0.7513235350482991
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.022134899	0.7507929067299642
PEHO SYNDROME; PEHO	0.022063563	0.7483732633064958
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003000000003	0.7480489979828394
FRANK-TER HAAR SYNDROME; FTHS	0.02203391	0.7473674641807232
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021977984000000002	0.7454705120373329
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.7451199934332883
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.021958864	0.7448219813900199
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02193308	0.7439474147472208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.7431984839578553
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504	0.74192665837461
ASPARTYLGLUCOSAMINURIA	0.021807449	0.7396861410153917
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02177467	0.7385743111990595
MAN1B1-CDG	0.021700113	0.736045414783175
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.021643443	0.7341232269284037
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.0216279	0.7335960244257266
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0216279	0.7335960244257266
9Q21.13 MICRODELETION SYNDROME	0.021596529	0.7325319525148033
PHOCOMELIA, SCHINZEL TYPE	0.021593479999999998	0.7324285335846957
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02158374	0.7320981628469956
PELGER-HUET ANOMALY; PHA	0.021570044	0.7316336086762006
CARTILAGE-HAIR HYPOPLASIA	0.02156183	0.7313549982820046
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.021432430000000002	0.7269658839638928
MICROPHTHALMIA, SYNDROMIC 1	0.021412859000000003	0.7263020558625037
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021386563	0.7254101227086468
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.021324523	0.7233057900015707
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.7231050236364324
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7220128329019408
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021283833000000002	0.7219256272380161
JABERI-ELAHI SYNDROME; JABELS	0.021278913000000003	0.7217587459208207
MYOPATHY, SPHEROID BODY	0.02124328	0.7205501113729281
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353000000002	0.7199420460531385
14Q22Q23 MICRODELETION SYNDROME	0.021223324	0.7198732244692786
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.021100294	0.7157001739703814
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7148077659509879
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123	0.7118954495331566
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.020975423000000003	0.7114646786534038
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.7114303187399241
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254	0.7110179997781703
16P11.2P12.2 MICRODELETION SYNDROME	0.020847004000000002	0.7071088388418304
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7066182349044489
MENTAL RETARDATION, X-LINKED 93	0.02082563	0.706383854843103
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020822319000000002	0.7062715491436652
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.020795098999999997	0.7053482748643836
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02075321	0.7039274432595045
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7035082048285007
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7035082048285007
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7035082048285007
FETAL TRIMETHADIONE SYNDROME	0.020695374	0.7019657058893165
10Q22.3Q23.3 MICRODELETION SYNDROME	0.020652343	0.7005061388242264
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.020641714000000002	0.7001456141249436
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.020641714000000002	0.7001456141249436
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020598054	0.6986647120296672
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.02056768	0.6976344573287527
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.02055111	0.6970724200470594
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.02055111	0.6970724200470594
DISTAL MYOPATHY, WELANDER TYPE	0.02055111	0.6970724200470594
TIBIAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470594
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470594
ADENYLOSUCCINASE DEFICIENCY	0.020519143000000004	0.695988132431858
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.020510204	0.6956849307866523
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.6953123648541164
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.020402499999999997	0.6920317223746127
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020397064	0.6918473388704919
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.02032355	0.6893538199370941
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.020301649999999997	0.6886109945617722
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.020286989999999998	0.6881137425068764
CORNELIA DE LANGE SYNDROME	0.020254649	0.6870167691980507
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.02022581	0.6860385801113427
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.020179114	0.6844547000325285
1P36 DELETION SYNDROME	0.020172443	0.6842284266042742
TURNPENNY-FRY SYNDROME; TPFS	0.020150404	0.6834808864925518
BRADDOCK SYNDROME	0.02014982	0.6834610778158765
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0201355	0.68297535820973
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.020122834	0.6825457405748521
MOEBIUS SYNDROME; MBS	0.020120930000000002	0.6824811588618561
SPINOCEREBELLAR ATAXIA 40; SCA40	0.01996123	0.6770642998463812
BAND HETEROTOPIA; BH	0.019954873	0.6768486769737365
SOTOS SYNDROME	0.019921083	0.6757025550818585
GABRIELE-DE VRIES SYNDROME; GADEVS	0.019902494000000003	0.6750720354059747
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01987247	0.6740536523434786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003	0.6728506483440931
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6717588307182377
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533	0.6713761908525298
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.019793024	0.6713589260983727
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.019751594	0.669953663299305
WRINKLY SKIN SYNDROME	0.019749724	0.6698902348311838
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.019749273	0.6698749373771076
MONOSOMY 18Q	0.019738843	0.6695211625522396
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.019735473	0.669406855633754
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.6690502655346325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6673882361560587
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.019614843000000003	0.6653152106554403
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6647540891858533
FRIAS SYNDROME	0.019592004	0.6645405353701901
KUSKOKWIM SYNDROME	0.01957728	0.6640411125014121
RAINE SYNDROME	0.019573004	0.6638960749989065
AASE-SMITH SYNDROME I	0.01956778	0.6637188823157703
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019518279	0.6620398595347745
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6614204991990038
NANCE-HORAN SYNDROME	0.019444740000000002	0.6595454926272041
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183	0.6593909238949967
1Q41Q42 MICRODELETION SYNDROME	0.019423459	0.6588236630923993
WARSAW BREAKAGE SYNDROME; WABS	0.019418274	0.6586477932489726
LYMPHEDEMA, HEREDITARY, III	0.019418274	0.6586477932489726
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01941391	0.6584997708773788
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.6583440489002965
HHHH SYNDROME	0.019409319	0.6583440489002965
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.6583440489002965
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01936954	0.6569947863155966
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.019303004	0.6547379539332945
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.019224769000000003	0.6520843035571162
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.01921181	0.6516447476649337
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.01921181	0.6516447476649337
KUFOR-RAKEB SYNDROME	0.01921181	0.6516447476649337
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.651449035225865
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.01920604	0.651449035225865
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004	0.6512443003415982
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004	0.6512443003415982
BOHRING-OPITZ SYNDROME	0.019180613	0.6505865776542527
DYSTONIA-APHONIA SYNDROME	0.019129043000000002	0.6488373765307208
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.019110134	0.6481960027854258
SALT-AND-PEPPER SYNDROME	0.019082104	0.6472452541429476
RABSON-MENDENHALL SYNDROME	0.019046854000000002	0.6460496105593817
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.01904645	0.6460359072967502
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.01904645	0.6460359072967502
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.01897163	0.6434980901925683
SPINOCEREBELLAR ATAXIA 42	0.01897163	0.6434980901925683
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083000000002	0.6414443985030884
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01887272	0.6401431651755325
PFEIFFER-PALM-TELLER SYNDROME	0.01887272	0.6401431651755325
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.639979675755028
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.639979675755028
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.639979675755028
KNUCKLE PADS	0.0188679	0.639979675755028
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.639979675755028
THROMBOCYTOPENIA 3	0.0188679	0.639979675755028
TOE, MISSHAPEN	0.0188679	0.639979675755028
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.639979675755028
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.639979675755028
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.639979675755028
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.639979675755028
RAYNAUD DISEASE	0.0188679	0.639979675755028
TRACHEOBRONCHOMEGALY	0.0188679	0.639979675755028
PUBIC BONE DYSPLASIA	0.0188679	0.639979675755028
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.639979675755028
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.639979675755028
CARPAL DISPLACEMENT	0.0188679	0.639979675755028
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.639979675755028
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.639979675755028
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.639979675755028
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.639979675755028
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.639979675755028
LETTERER-SIWE DISEASE	0.0188679	0.639979675755028
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.639979675755028
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.639979675755028
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.639979675755028
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.639979675755028
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.639979675755028
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.639979675755028
SPINAL ARACHNOIDITIS	0.0188679	0.639979675755028
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.639979675755028
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.639979675755028
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.639979675755028
MONOPHALANGY OF GREAT TOE	0.0188679	0.639979675755028
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.639979675755028
NEPHROSIALIDOSIS	0.0188679	0.639979675755028
VAN DEN BOSCH SYNDROME	0.0188679	0.639979675755028
VESICOURETERAL REFLUX 1	0.0188679	0.639979675755028
48,XXYY SYNDROME	0.018847292999999998	0.6392807076039202
COHEN SYNDROME	0.018836309000000002	0.6389081416713845
SPINOCEREBELLAR ATAXIA TYPE 38	0.018826250000000003	0.6385669507832401
FREE SIALIC ACID STORAGE DISEASE	0.018820953	0.6383872820155195
HSD10 DISEASE	0.018820953	0.6383872820155195
MIETENS SYNDROME	0.018639193999999998	0.632222204508984
MARSHALL-SMITH SYNDROME	0.01863731	0.6321583011753263
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.6295088906700117
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.018543413	0.6289734119394087
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6287406260695076
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0185185	0.628128388716788
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0185185	0.628128388716788
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0185185	0.628128388716788
HYPEREKPLEXIA 4; HKPX4	0.018479873	0.6268182007819681
TRISOMY 17P	0.018479603999999997	0.6268090765798693
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.018467139	0.6263862766573403
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.018427214	0.6250320619034716
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.018415459000000002	0.6246333444474484
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.018400223	0.6241165550676127
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.018400223	0.6241165550676127
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.018400223	0.6241165550676127
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01839085	0.6237986325907682
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018385794	0.6236271382940729
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.018365529000000002	0.6229397704296484
LATHOSTEROLOSIS	0.018353869000000002	0.6225442752754816
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0183277	0.6216566498304223
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0183277	0.6216566498304223
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.018279534	0.620022908870251
CHOREOACANTHOCYTOSIS	0.018275399	0.6198826539420795
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.018275399	0.6198826539420795
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.01826711	0.6196014996253653
CRI-DU-CHAT SYNDROME	0.018263630000000003	0.6194834616205197
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6193584023895236
SMITH-LEMLI-OPITZ SYNDROME	0.018245903	0.6188821800941118
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.018211173	0.6177041743733389
JOUBERT SYNDROME 14	0.018118824	0.6145717916981973
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018115883	0.614472036016516
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018113994	0.6144079630880237
WIEACKER-WOLFF SYNDROME	0.018075373000000002	0.6130979786670052
ZLOTOGORA-OGUR SYNDROME	0.018032719	0.6116511990524399
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.6110902132587208
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.018008259000000002	0.6108215411218294
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.017984014000000003	0.6099991757691045
COFFIN-SIRIS SYNDROME 7; CSS7	0.017984014000000003	0.6099991757691045
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.01797794	0.609793151964095
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.01797794	0.609793151964095
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01797794	0.609793151964095
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.01794871	0.6088017005613251
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.017934049999999997	0.6083044485064293
ANTLEY-BIXLER SYNDROME	0.017934049999999997	0.6083044485064293
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921154	0.6078670295091623
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.017864729000000003	0.605953151801284
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017864729	0.605953151801284
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.017846503000000003	0.6053349447103883
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017843083000000003	0.6052189418435572
RIN2 SYNDROME	0.01783647	0.6049946357153835
MACS SYNDROME	0.01783647	0.6049946357153835
AL-RAQAD SYNDROME; ARS	0.017824614	0.6045924924437023
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.017784633	0.6032363782276867
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6024117063852117
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.6012344808006778
MOEBIUS SYNDROME	0.01766471	0.5991687139589779
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.017662629	0.5990981285888388
PELVIS-SHOULDER DYSPLASIA	0.01763723	0.5982366207483001
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.017582533	0.5963813550152417
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.017578200000000002	0.5962343841316222
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017551353	0.5953237616269981
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.017529264	0.5945745255669302
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017442104	0.5916181484110832
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.017395233000000003	0.59002833251306
MEIER-GORLIN SYNDROME 3; MGORS3	0.01738817	0.5897887628497769
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.017381784	0.5895721563270917
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.589526569235565
GAPO SYNDROME; GAPOS	0.017305238999999997	0.5869758290049906
CEREBELLAR ATAXIA, CAYMAN TYPE	0.017301664	0.5868545686982887
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.017301664	0.5868545686982887
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.017297529	0.5867143137701171
JUVENILE HUNTINGTON DISEASE	0.017297529	0.5867143137701171
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314000000002	0.5855537763173027
HYPERPROLINEMIA, TYPE I	0.017254172999999998	0.5852437230407812
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.01724419	0.584905109994122
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.0172414	0.5848104760764441
269800 SENILE PLAQUE FORMATION	0.0172414	0.5848104760764441
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.5848104760764441
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.5848104760764441
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.5848104760764441
ALCOHOL DEPENDENCE	0.0172414	0.5848104760764441
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.5848104760764441
MOTION SICKNESS	0.0172414	0.5848104760764441
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.5848104760764441
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.5848104760764441
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.5848104760764441
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.5848104760764441
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.5848104760764441
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.5848104760764441
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.5848104760764441
TRANSSEXUALITY	0.0172414	0.5848104760764441
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.5848104760764441
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.5848104760764441
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.5848104760764441
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.5848104760764441
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.5848104760764441
PALMOMENTAL REFLEX	0.0172414	0.5848104760764441
BARTSOCAS-PAPAS SYNDROME; BPS	0.0172414	0.5848104760764441
JUMPING FRENCHMAN OF MAINE	0.0172414	0.5848104760764441
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.5848104760764441
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.5848104760764441
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.5848104760764441
CARDIAC ARRHYTHMIA	0.0172414	0.5848104760764441
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.5848104760764441
MOSAIC TRISOMY 15	0.0172414	0.5848104760764441
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.5848104760764441
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0172414	0.5848104760764441
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.5848104760764441
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.5848104760764441
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.5848104760764441
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.5848104760764441
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.5848104760764441
CERVICAL RIB	0.0172414	0.5848104760764441
MYOPATHY, CONGENITAL	0.0172414	0.5848104760764441
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.5848104760764441
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.5848104760764441
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.5848104760764441
DIASTEMATOMYELIA	0.0172414	0.5848104760764441
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.5848104760764441
SICKLE CELL ANEMIA	0.0172414	0.5848104760764441
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.5848104760764441
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.5848104760764441
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0172414	0.5848104760764441
ERYTHERMALGIA, PRIMARY	0.0172414	0.5848104760764441
RHEUMATOID ARTHRITIS	0.0172414	0.5848104760764441
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.5848104760764441
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.5848104760764441
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.5848104760764441
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.5823229947191563
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.01712121	0.5807337554435704
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.01712121	0.5807337554435704
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.01712121	0.5807337554435704
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.01712121	0.5807337554435704
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.5801927479213611
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.5800914658861688
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.5777706962512421
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.016991793	0.5763440645030212
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.016973164	0.5757121880684608
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.016945979	0.5747901009530214
FACIOCARDIORENAL SYNDROME	0.016899169999999998	0.5732023880309465
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01689443	0.5730416121277946
NEMALINE MYOPATHY 4	0.01689443	0.5730416121277946
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.01689443	0.5730416121277946
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.01689443	0.5730416121277946
MENTAL RETARDATION, X-LINKED 9	0.016866303	0.5720875733455262
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.016853483000000002	0.5716527321897443
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.016839383	0.5711744747563179
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.016812793000000003	0.5702725694261898
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.01675611	0.5683499406248487
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01675611	0.5683499406248487
UROCANIC ACIDURIA	0.01675611	0.5683499406248487
COFFIN-LOWRY SYNDROME; CLS	0.016739519	0.5677871910448502
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.016732113000000003	0.5675359871759174
DESBUQUOIS DYSPLASIA 1	0.0167202	0.5671319105231223
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5668793498955128
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5668793498955128
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016701364	0.5664930128624116
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016701364	0.5664930128624116
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.5659359277498871
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.01668354	0.5658884411962136
MARDEN-WALKER SYNDROME	0.016674553999999998	0.5655836453595633
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.5655836453595633
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.5655836453595633
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.5654433904313918
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.5654433904313918
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.01663864	0.5643654795819693
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.016635843	0.564270608231523
6Q TERMINAL DELETION SYNDROME	0.016631883000000004	0.5641362891225608
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01662251	0.5638183666457163
AU-KLINE SYNDROME; AUKS	0.016598324	0.5629980025120389
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.56295628218274
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.01655401	0.5614949174124036
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.01655401	0.5614949174124036
ZIMMERMANN-LABAND SYNDROME 1	0.016488299	0.5592660681778021
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0163957	0.5561252057609332
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016373874	0.5553848903891626
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424000000002	0.5550643561518663
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.5540622541934869
WIEDEMANN-STEINER SYNDROME	0.016332479	0.5539808147539367
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016320749000000002	0.5535829452720863
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.016316853	0.5534507969770062
GAUCHER DISEASE	0.016301509999999998	0.552930378267711
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.552930378267711
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5526530567942576
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.5511947447309431
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.016233654	0.5506287728490883
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.016170554	0.5484884860370879
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.016166419	0.5483482311089164
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.016166419	0.5483482311089164
PENTALOGY OF CANTRELL	0.016128999999999998	0.5470790172861232
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.5470790172861232
DIGITOTALAR DYSMORPHISM	0.016128999999999998	0.5470790172861232
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.5470790172861232
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.016128999999999998	0.5470790172861232
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.5470790172861232
ACALVARIA	0.016128999999999998	0.5470790172861232
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.5470790172861232
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.5470790172861232
TERMINAL TRANSVERSE LIMB DEFECT	0.016128999999999998	0.5470790172861232
MECKEL SYNDROME, TYPE 1; MKS1	0.016128999999999998	0.5470790172861232
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.5470790172861232
MECKEL SYNDROME	0.016128999999999998	0.5470790172861232
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.016128999999999998	0.5470790172861232
GORDON SYNDROME	0.016128999999999998	0.5470790172861232
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.5470790172861232
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.016109964	0.5464333358320308
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01609075	0.5457816168018284
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.5441604258594135
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.01603142	0.5437692044950774
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.01603002	0.5437217179414038
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.5426927182422651
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.015846259	0.5374887346631153
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.01576651	0.5347837309710357
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.015733334	0.5336584353248405
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5306072885754477
6Q16 MICRODELETION SYNDROME	0.015642334	0.5305718093360602
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.015625	0.5299838579636479
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.015625	0.5299838579636479
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.015625	0.5299838579636479
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.015625	0.5299838579636479
GNE MYOPATHY	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.015625	0.5299838579636479
MYOPATHY, DISTAL, INFANTILE-ONSET	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.015625	0.5299838579636479
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.015625	0.5299838579636479
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.015625	0.5299838579636479
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.015625	0.5299838579636479
WELANDER DISTAL MYOPATHY; WDM	0.015625	0.5299838579636479
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.015625	0.5299838579636479
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01561356	0.5295958249822011
KEIPERT SYNDROME	0.015611580000000002	0.52952866542772
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.01556441	0.5279287077585908
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.01556441	0.5279287077585908
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.01556441	0.5279287077585908
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.01556441	0.5279287077585908
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.5273903798347673
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015480023	0.5250663878979841
RING CHROMOSOME 14 SYNDROME	0.015476223999999998	0.5249375297426943
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5247587767870803
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5247587767870803
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5247587767870803
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.015417573	0.522948148414475
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.015374479000000002	0.5214864444544696
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5214251868002306
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5211436932938472
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01535388	0.5207877476550972
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5204499147446768
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01524879	0.5172232034225596
HENNEKAM-BEEMER SYNDROME	0.015232619	0.5166746998086632
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.015138990000000001	0.5134989008558775
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.5122453575957967
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5117396257991734
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01502789	0.5097305036322127
OROFACIODIGITAL SYNDROME TYPE 2	0.015016924000000001	0.5093585482410813
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.015013642999999998	0.5092472601106506
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014959674000000001	0.5074166873855025
ACROCRANIOFACIAL DYSOSTOSIS	0.01494989	0.5070848242132583
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.014938604000000001	0.5067020147527157
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.014928303	0.5063526154745791
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01492611	0.5062782311801461
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5062541487136403
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5062541487136403
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5062541487136403
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923059	0.5061747444121049
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.5053179852269333
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.5053179852269333
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.5053179852269333
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.014884783	0.5048764620346701
SCARF SYNDROME	0.01488284	0.5048105574819646
LAMB-SHAFFER SYNDROME	0.014875134000000002	0.5045491779229587
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014845379	0.5035399190625613
JOUBERT SYNDROME 2	0.014831254	0.5030608136549622
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.5030608136549622
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.5030608136549622
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.5030608136549622
DEXTROCARDIA	0.014831254	0.5030608136549622
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.5030608136549622
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.5030608136549622
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.5030608136549622
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.5030608136549622
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01480813	0.5022764714641428
SAY-BARBER-MILLER SYNDROME	0.014802593999999999	0.502088696063331
GAUCHER DISEASE, PERINATAL LETHAL	0.014789139	0.5016323163635612
DISTAL MONOSOMY 10P	0.01476133	0.5006890638127701
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688442999999999	0.4982168120716248
X SMALL RINGS	0.014683604	0.49805267819074894
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014682933	0.4980299185639525
SMITH-FINEMAN-MYERS SYNDROME	0.014679989	0.49793006112537036
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.01467102	0.4976258419111576
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.01467102	0.4976258419111576
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.014666644	0.49747741251196087
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652278999999999	0.4969901665523033
3Q29 MICRODELETION SYNDROME	0.014591444000000002	0.49492670620035345
NEONATAL ADRENOLEUKODYSTROPHY	0.014586368999999998	0.4947545674432867
ACRODYSOSTOSIS	0.01457371	0.49432518724117724
KBG SYNDROME	0.014552433	0.49360349338224013
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.4932349977257335
DISTAL ANOCTAMINOPATHY	0.01454149	0.4932323181273476
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.01454149	0.4932323181273476
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803	0.49290374509489354
ARGININEMIA	0.014531803	0.49290374509489354
HURLER SYNDROME	0.014527794	0.49276776395655264
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.014525360000000001	0.4926852051910946
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.014523343000000001	0.49261679063483776
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.4910691020937162
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.49011753939603225
AMISH LETHAL MICROCEPHALY	0.01444966	0.49011753939603225
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.49011753939603225
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014426779	0.489341439514172
6Q25 MICRODELETION SYNDROME	0.014424493000000002	0.48926390075581655
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.01441446	0.48892359176081174
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0144089	0.488735002304794
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014386884	0.48798824232931065
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0143777	0.48767673053721217
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.014366723	0.4873044020374447
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.014346413	0.48661550781950924
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.4854180326117301
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.48455618558152214
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.48455618558152214
INFANT BOTULISM	0.0142857	0.48455618558152214
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.48455618558152214
WILSON DISEASE	0.0142857	0.48455618558152214
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.48455618558152214
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.48455618558152214
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.48455618558152214
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.48455618558152214
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.48455618558152214
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.48455618558152214
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.48455618558152214
HYPOPHOSPHATASIA, ADULT	0.0142857	0.48455618558152214
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.48455618558152214
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.48455618558152214
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.48395968662944866
KABUKI SYNDROME	0.014263029	0.48378720868271297
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.4836569937687467
MENTAL RETARDATION, X-LINKED 45	0.014257039999999999	0.4835840679898909
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.48314698818229285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.014222634	0.4824170520143967
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01418537	0.4811530956314747
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0141756	0.4808217073247672
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.014127204	0.47918016500220667
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.014109179999999999	0.47856880954262654
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01407476	0.4774013187015957
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.4767524488646136
CHST3-RELATED SKELETAL DYSPLASIA	0.014017499999999999	0.4754591186563477
FONTAINE PROGEROID SYNDROME; FPS	0.014015060000000001	0.4753763563770882
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.014007094000000001	0.4751061578866857
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.014007094000000001	0.4751061578866857
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699000000001	0.474516137457292
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249	0.47439911702145354
ANGELMAN SYNDROME	0.013986249	0.47439911702145354
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249	0.47439911702145354
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.01398084	0.47421564932943916
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01398084	0.47421564932943916
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.013964279000000001	0.47365391731844814
CARNOSINASE DEFICIENCY	0.013932159999999999	0.47256447402027624
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.013916929	0.47204785423527496
SPINOCEREBELLAR ATAXIA TYPE 21	0.013900140000000002	0.47147838869982855
GM1 GANGLIOSIDOSIS	0.013834389	0.46924818270655055
LISSENCEPHALY 8; LIS8	0.013789673	0.4677314621822176
NATIVE AMERICAN MYOPATHY	0.01375724	0.46663136832843616
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.46656827904998416
MEIER-GORLIN SYNDROME 6; MGORS6	0.01375064	0.46640750314683227
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4646423601088528
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4646423601088528
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4646423601088528
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.4646423601088528
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.4646423601088528
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.46371209852238815
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819	0.4633608676200385
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.46226779499240744
HALL-RIGGS SYNDROME	0.013593969	0.46109338468212685
MENKES DISEASE	0.013586849	0.46085188163773
MOSAIC TRISOMY 14	0.013579092999999999	0.4605888061303785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.013536794	0.45915406774906625
SPINOCEREBELLAR ATAXIA TYPE 13	0.013494233	0.4577104425984237
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013475493	0.4570748011585364
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.456831262976125
SYRINGOMYELIA, ISOLATED	0.013461540000000001	0.45660152981324575
SPINOCEREBELLAR ATAXIA TYPE 8	0.013461540000000001	0.45660152981324575
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.013461540000000001	0.45660152981324575
CHIARI MALFORMATION TYPE I	0.013461540000000001	0.45660152981324575
SPINOCEREBELLAR ATAXIA TYPE 43	0.013461540000000001	0.45660152981324575
SPINOCEREBELLAR ATAXIA TYPE 6	0.013461540000000001	0.45660152981324575
TRISOMY 9P	0.013448494	0.45615902297094213
OROFACIODIGITAL SYNDROME TYPE 6	0.013424083	0.45533102706971007
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.013413309	0.45496558412022525
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.013340999999999999	0.4525129375419536
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.013340999999999999	0.4525129375419536
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.45136589983796926
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.45136589983796926
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.4505141945788674
SECKEL SYNDROME 7; SCKL7	0.013267979	0.45003614065924236
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.013263408999999999	0.44988113098046517
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.01325944	0.44974650660080073
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.01325944	0.44974650660080073
KRABBE DISEASE	0.013253094	0.4495312568367919
GERMAN SYNDROME	0.013243814	0.4492164888238701
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.013230179999999998	0.4487540376290236
KLEEFSTRA SYNDROME	0.013229809	0.44874145369230023
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.013167282999999998	0.4466206363673059
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.013122213999999998	0.4450919424476538
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013111733	0.44473643775547356
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.442697229464864
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.442697229464864
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.013029019999999999	0.44193089824547366
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.012992150000000001	0.44068030593551416
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01299124	0.44064943967562625
PFEIFFER SYNDROME	0.01294239	0.43899249814208874
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012909309	0.43787042479774985
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.43728410153574926
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.012863633999999999	0.43632117598415043
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.4356855006252963
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.43563723393538384
MONOSOMY 5P	0.012808420000000001	0.4344483741451998
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.4336794311653575
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.43286127176452927
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.43286127176452927
FAMILIAL DYSAUTONOMIA	0.012761629	0.43286127176452927
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.43286127176452927
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.43286127176452927
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.4321498214335989
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.4321498214335989
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.4321498214335989
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.4320095665054273
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.4320095665054273
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.4320095665054273
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.4320095665054273
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.012714873	0.43127535654770055
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.012714873	0.43127535654770055
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.012714393	0.43125907544358394
GAUCHER DISEASE TYPE 3	0.01270754	0.43102662876335196
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.012690228999999999	0.43043945752717855
KNIEST-LIKE DYSPLASIA, LETHAL	0.01268839	0.4303770805470317
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.012621728999999998	0.42811600829386587
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.4276981605405057
JOHNSON NEUROECTODERMAL SYNDROME	0.01258868	0.42699502035646814
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4267437825685681
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.012576659999999998	0.42658731437421377
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012570314	0.42637206461020505
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603	0.42607659648945484
MONOSOMY 22Q13.3	0.012540662999999999	0.4253663333223663
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.012513914000000001	0.42445903487649955
DUCHENNE MUSCULAR DYSTROPHY	0.012513874	0.42445767811782303
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.42433285631959555
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.42419260139142395
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01247786	0.42323612044353814
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.012459853000000002	0.4226253416063957
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012453503	0.4224099561665192
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.01244335	0.4220655768954853
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.41980996559599204
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.4189989630971817
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.4189197283904807
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01233253	0.41830667698255525
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.41798441287794647
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.012318079999999999	0.4178165479107105
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.012318079999999999	0.4178165479107105
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.012318079999999999	0.4178165479107105
GENITOPATELLAR SYNDROME; GTPTS	0.012310813999999998	0.41757009269714473
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.4158704132653011
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.41449689861926076
NEUROFERRITINOPATHY	0.01222021	0.41449689861926076
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.41449689861926076
CORTICOBASAL SYNDROME	0.01222021	0.41449689861926076
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.41449689861926076
RHEUMATIC FEVER	0.01222021	0.41449689861926076
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.41449689861926076
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.41449689861926076
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.012196592999999999	0.4136958343777549
RAMOS-ARROYO SYNDROME	0.0121951	0.41364519336015887
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.41364519336015887
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.41364519336015887
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.41364519336015887
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.41364519336015887
JOUBERT SYNDROME 4	0.0121951	0.41364519336015887
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.41364519336015887
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.41364519336015887
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.41364519336015887
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012176874	0.41302698626926315
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.012173454	0.41291098340243204
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.012173454	0.41291098340243204
MENTAL RETARDATION, X-LINKED 102	0.012169319	0.41277072847426055
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.012169319	0.41277072847426055
CEREBROFACIOARTICULAR SYNDROME	0.012163364	0.41256874102631347
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.012110869	0.41078816485839015
MELNICK-NEEDLES SYNDROME	0.012088149999999999	0.4100175598491692
BARTH SYNDROME; BTHS	0.012088149999999999	0.4100175598491692
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024	0.40967409639024194
CHROMOSOME 9P DELETION SYNDROME	0.012078024	0.40967409639024194
FUMARASE DEFICIENCY; FMRD	0.012039854	0.40837940942329964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.40837940942329964
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.40837940942329964
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.40837940942329964
PALLISTER-KILLIAN SYNDROME	0.011995108999999999	0.4068617052489263
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01196832	0.4059530500443831
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.01196832	0.4059530500443831
NEMALINE MYOPATHY 3; NEM3	0.01196832	0.4059530500443831
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01196832	0.4059530500443831
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.01196832	0.4059530500443831
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01196832	0.4059530500443831
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.4053428478296781
COCKAYNE SYNDROME A; CSA	0.011926209	0.4045246884288498
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01192077	0.40434020316782815
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01192077	0.40434020316782815
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.011918434000000002	0.4042609684611272
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.40094230281971777
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.39933623973654475
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.3988164994065878
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.3988164994065878
MOSAIC TRISOMY 1	0.0117062	0.3970622104380195
8P23.1 MICRODELETION SYNDROME	0.011696313	0.39672685361218357
CEDNIK SYNDROME	0.011684583	0.3963289841303331
AYME-GRIPP SYNDROME; AYGRP	0.011679439	0.39615450496454974
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.39594898994404404
SNEDDON SYNDROME	0.011666289	0.3957084705496875
PSEUDOACHONDROPLASIA	0.01166456	0.3956498246559007
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.01166456	0.3956498246559007
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3956292358429866
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.011649879	0.3951518603026998
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.011647402999999999	0.3950678769406314
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0116279	0.39440635532899204
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0116279	0.39440635532899204
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.0116279	0.39440635532899204
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01161781	0.3940641129528734
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01161781	0.3940641129528734
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.3940369777793457
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.3940369777793457
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01160355	0.3935804284847415
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.011567753	0.39236623122627595
SHPRINTZEN-GOLDBERG SYNDROME	0.01154303	0.3915276526073681
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.39053586201492924
PMM2-CDG	0.011510853	0.39043624200911553
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.39019270382670407
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.39019270382670407
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.39019270382670407
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.39019270382670407
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.39019270382670407
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.39019270382670407
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.39019270382670407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.38987478134985964
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.38987478134985964
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.38987478134985964
RING CHROMOSOME 22 SYNDROME	0.011430733	0.3877186543803125
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01142043	0.38736918726424213
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011385199	0.3861741881410474
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.3855455000893766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.38265716438115027
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.379375640008507
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.379375640008507
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.011183854	0.3793447737486192
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.011179719	0.37920451882044764
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011179719	0.37920451882044764
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.011179719	0.37920451882044764
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.37734409740441904
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.3760586703154431
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.3760586703154431
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.3755732898989657
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.011051623	0.37485963483518614
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0110272	0.3740312319063512
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.3727057804364219
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.01095955	0.3717366137949118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.37168807575326407
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.37168807575326407
XYLOSIDASE DEFICIENCY	0.010958119	0.37168807575326407
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.37168807575326407
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.37168807575326407
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.37168807575326407
FETAL ALCOHOL SYNDROME	0.010948804000000001	0.3713721205765005
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01086549	0.3685461957673879
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.010847729	0.36794376099610526
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.010839472999999999	0.3676637260052989
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.3672926525073072
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.36617943201333164
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.36617943201333164
RECOMBINANT 8 SYNDROME	0.010795713	0.36617943201333164
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010783629999999999	0.36576958913616203
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010756223999999998	0.3648400059290355
PROTEUS SYNDROME	0.010733620000000001	0.3640733016010093
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01070843	0.3632188828245546
DYSTONIA 16	0.01068627	0.3624672385178362
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.3624672385178362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010686223	0.36246564432639145
%608572 BURN-MCKEOWN SYNDROME	0.01067281	0.36201068922323204
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.01067281	0.36201068922323204
WOODHOUSE-SAKATI SYNDROME	0.01067281	0.36201068922323204
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010654803000000001	0.3613999103860896
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.360871011935067
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.360871011935067
AASE-SMITH SYNDROME	0.01063921	0.360871011935067
HYDROLETHALUS SYNDROME 1	0.01063921	0.360871011935067
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0106383	0.3608401456751792
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0106383	0.3608401456751792
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA-NEUROPATHY-POIKILODERMA SYNDROME	0.0106383	0.3608401456751792
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0106383	0.3608401456751792
PRIMARY LATERAL SCLEROSIS, ADULT	0.0106383	0.3608401456751792
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0106383	0.3608401456751792
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0106383	0.3608401456751792
EPISODIC ATAXIA, TYPE 1; EA1	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.0106383	0.3608401456751792
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.0106383	0.3608401456751792
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.3608401456751792
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0106383	0.3608401456751792
SPASTIC PARAPLEGIA TYPE 2	0.0106383	0.3608401456751792
PRIMARY LATERAL SCLEROSIS	0.0106383	0.3608401456751792
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.36082739214362114
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01059269	0.359293101594429
MONOSOMY 22	0.01055989	0.35818055947979177
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.35769429717017465
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.35769429717017465
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.35769429717017465
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.35769429717017465
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3572089167536972
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.01052012	0.356831602165794
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.3558279399349368
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.3558279399349368
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.3533237026079956
DEAFNESS-HYPOGONADISM SYNDROME	0.010403250000000001	0.3528674925030605
MILROY DISEASE	0.010403250000000001	0.3528674925030605
HUNTINGTON DISEASE-LIKE 1	0.010342529	0.35080789891333813
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010332819	0.35047854574464526
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114	0.34892827936203863
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.3480640240851801
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010260353	0.34802057388856883
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.3478150588680632
STURGE-WEBER SYNDROME	0.010250159	0.34767480393989164
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.34767480393989164
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010220064000000001	0.346654012630745
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.010183850000000001	0.34542567116307815
RIGID SPINE SYNDROME	0.010160934	0.344648384117376
ZEBRA BODY MYOPATHY	0.010160934	0.344648384117376
HYPOPHOSPHATASIA, CHILDHOOD	0.010156799	0.3445081291892045
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149532999999999	0.3442616739756388
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010138204	0.34387740599951916
ABLEPHARON MACROSTOMIA SYNDROME	0.010138204	0.34387740599951916
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010134068999999999	0.3437371510713476
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.34289528231264954
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010109249	0.34289528231264954
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.34232276407018114
FILIPPI SYNDROME	0.010064993	0.341394164513095
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.01005432	0.34103214737926807
SPINOCEREBELLAR ATAXIA TYPE 35	0.01005432	0.34103214737926807
SPINOCEREBELLAR ATAXIA TYPE 27	0.01005432	0.34103214737926807
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.01005432	0.34103214737926807
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033372999999998	0.34032164677941107
TRISOMY 8Q	0.010023854	0.339998772133398
WOLCOTT-RALLISON SYNDROME	0.010023138999999999	0.33997452007205753
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.33971687159941166
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.33971687159941166
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.33971687159941166
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.33971687159941166
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.33918966909673465
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.33918966909673465
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.33918966909673465
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.33918966909673465
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.33918966909673465
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.33918966909673465
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.33918966909673465
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009998008999999999	0.33912213643361744
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.33912213643361744
KEIPERT SYNDROME; KPTS	0.00998569	0.3387042886802572
PELVISCAPULAR DYSPLASIA	0.00998569	0.3387042886802572
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009975802999999998	0.3383689318544212
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.009948163000000001	0.33743141160903795
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00991864	0.3364300219489636
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00991864	0.3364300219489636
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.33625462697107367
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.33625462697107367
FRYNS SYNDROME	0.009913469	0.33625462697107367
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.33583677921771343
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.33583677921771343
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.33583677921771343
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.33583677921771343
BARBER-SAY SYNDROME	0.009901150000000001	0.33583677921771343
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009891262999999999	0.33550142239187747
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.3344038046226805
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.3344038046226805
INFANTILE REFSUM DISEASE	0.009858903	0.3344038046226805
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.3344038046226805
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.33256916162150313
BIOTINIDASE DEFICIENCY	0.009804814	0.33256916162150313
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.33256916162150313
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.33256916162150313
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3324289066933316
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3324289066933316
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.009799413	0.332385965281224
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.009795044	0.33223777331479554
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.009790909	0.3320975183866241
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.009790909	0.3320975183866241
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009788573	0.3320182836799231
2Q24 MICRODELETION SYNDROME	0.009753879	0.33084149904195886
LOWRY-MACLEAN SYNDROME	0.009753879	0.33084149904195886
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743583	0.3304922693586569
JOUBERT SYNDROME	0.009743583	0.3304922693586569
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743583	0.3304922693586569
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.3304236512885987
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.3304236512885987
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009718934	0.3296562007433004
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.32955939601174006
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.32955939601174006
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.3293104307946232
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.3293104307946232
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.3293104307946232
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.3293104307946232
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.3293104307946232
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.3293104307946232
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.3293104307946232
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.3293104307946232
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.3293104307946232
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.3293104307946232
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.3293104307946232
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.3293104307946232
ENAMEL-RENAL SYNDROME	0.00970874	0.3293104307946232
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.3293104307946232
OTODENTAL SYNDROME	0.00970874	0.3293104307946232
HYPOPLASMINOGENEMIA	0.00970874	0.3293104307946232
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.3293104307946232
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00967451	0.328149384557305
TREACHER-COLLINS SYNDROME	0.009634394000000001	0.3267886912807566
17Q24.2 MICRODELETION SYNDROME	0.009630259	0.32664843635258506
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00961538	0.32614375604393603
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00961538	0.32614375604393603
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00961538	0.32614375604393603
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.00961538	0.32614375604393603
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00961538	0.32614375604393603
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00961538	0.32614375604393603
CAMURATI-ENGELMANN DISEASE	0.00961538	0.32614375604393603
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00961538	0.32614375604393603
TYPICAL NEMALINE MYOPATHY	0.00961538	0.32614375604393603
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00961538	0.32614375604393603
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.00961538	0.32614375604393603
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00961538	0.32614375604393603
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00961538	0.32614375604393603
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00961538	0.32614375604393603
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00961538	0.32614375604393603
CZECH DYSPLASIA, METATARSAL TYPE	0.00961538	0.32614375604393603
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00961538	0.32614375604393603
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00961538	0.32614375604393603
CAMURATI-ENGELMANN DISEASE	0.00961538	0.32614375604393603
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00961538	0.32614375604393603
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00961538	0.32614375604393603
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00961538	0.32614375604393603
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.3245309091673811
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.009542349999999998	0.3236666538905225
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009530794	0.32327468630891437
OGDEN SYNDROME; OGDNS	0.009530794	0.32327468630891437
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.32302979136782656
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.32161387801314917
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.3213524984541432
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.3213524984541432
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.32121224352597166
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.32121224352597166
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.32121224352597166
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.32121224352597166
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009454179	0.3206759846591298
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009442269	0.32027200976323555
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.31952694573609763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.31952694573609763
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.31952694573609763
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.31952694573609763
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.31952694573609763
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.31952694573609763
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.318675138720095
W SYNDROME	0.009392854	0.31859590401339405
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.009349844	0.31713704924660896
FORSYTHE-WAKELING SYNDROME; FWS	0.009338114	0.3167391797647585
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00933297	0.3165647005989751
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00933297	0.3165647005989751
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.3164347909557111
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3160394314774119
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3160394314774119
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.3160394314774119
2Q33.1 DELETION SYNDROME	0.009313349	0.31589917654924043
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.31589917654924043
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.31589917654924043
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.31589917654924043
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.31589917654924043
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.31589917654924043
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.31589917654924043
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.31589917654924043
PINEOBLASTOMA	0.009313349	0.31589917654924043
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.31589917654924043
SCLERODERMA	0.009313349	0.31589917654924043
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00930341	0.3155620559371252
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.009301074	0.31548282123042415
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.31406453354806313
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.31406453354806313
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.31406453354806313
GAUCHER DISEASE TYPE 2	0.00925926	0.31406453354806313
PAINE SYNDROME	0.00925926	0.31406453354806313
CARNOSINEMIA	0.00925926	0.31406453354806313
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.31406453354806313
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.31406453354806313
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.31406453354806313
HYDROXYLYSINURIA	0.00925926	0.31406453354806313
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.31406453354806313
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00923417	0.3132135066682994
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00922215	0.31280580068604513
1Q44 MICRODELETION SYNDROME	0.009219124	0.31270316189217645
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.31233103690621045
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.3119876412852169
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009190254	0.3117239213174942
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.009108823	0.30896186592307257
NON-DISTAL MONOSOMY 10Q	0.00909342	0.30843941207576286
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00908884	0.3082840632073166
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00908884	0.3082840632073166
DUBOWITZ SYNDROME	0.00906044	0.3073207645470818
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00904871	0.30692289506523135
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00904871	0.30692289506523135
MCDONOUGH SYNDROME	0.00904871	0.30692289506523135
CHARGE-LIKE SYNDROME, X-LINKED	0.00904871	0.30692289506523135
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00904871	0.30692289506523135
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.3065843837754728
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.009037564	0.30654483426005613
CARPENTER SYNDROME	0.00902538	0.30613156556722865
DESANTO-SHINAWI SYNDROME	0.009023483	0.3060672212870011
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009005222999999998	0.30544786095123033
GENITOPATELLAR SYNDROME	0.008998003	0.3052029660101425
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.3028478703807032
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.3028478703807032
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.3011625725908292
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.3011625725908292
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.3011625725908292
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.3011625725908292
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.3011625725908292
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.30102231766265763
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.30102231766265763
INCONTINENTIA PIGMENTI	0.008808752999999999	0.29878380152248685
600736 VELOFACIOSKELETAL SYNDROME	0.00880429	0.29863242117316896
DERMOTRICHIC SYNDROME	0.008798549	0.29843769238414053
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008798549	0.29843769238414053
NIJMEGEN BREAKAGE SYNDROME	0.00879256	0.2982345516913185
NANCE-HORAN SYNDROME	0.00879256	0.2982345516913185
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00879256	0.2982345516913185
BREATH-HOLDING SPELLS	0.00877193	0.2975348034039719
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.2975348034039719
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.2975348034039719
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.2975348034039719
HISTIDINEMIA	0.00877193	0.2975348034039719
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.2975348034039719
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.2975348034039719
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.2975348034039719
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.2975348034039719
CAFFEY DISEASE	0.00877193	0.2975348034039719
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.2975348034039719
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.2975348034039719
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008759063	0.2970983680567451
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.008755520000000001	0.29697819315698426
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00875552	0.29697819315698415
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008712734	0.2955269362387869
SECKEL SYNDROME 9; SCKL9	0.008712734	0.2955269362387869
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.008708599	0.2953866813106154
ALEXANDER DISEASE	0.008662599	0.29382640883277045
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.29382640883277045
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.29382640883277045
CADASIL	0.008662599	0.29382640883277045
PARTINGTON SYNDROME	0.008662599	0.29382640883277045
WEAVER SYNDROME	0.008637533999999999	0.2929762299271794
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.2914005582383575
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588744	0.2913213235316565
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584609	0.29118106860348497
RUBINSTEIN-TAYBI SYNDROME	0.008537163	0.28957174929948865
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.28812069589509276
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.28812069589509276
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.28812069589509276
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.28812069589509276
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.2877028481417325
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.2877028481417325
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.2877028481417325
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.28756259321356104
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.28756259321356104
LATERAL MENINGOCELE SYNDROME	0.00843149	0.28598743030924273
COFFIN-SIRIS SYNDROME 6; CSS6	0.008384044	0.28437811100524635
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.008376464	0.28412100523607103
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.28303624275533273
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.008336109999999999	0.282752239245398
SYDENHAM CHOREA	0.00833333	0.2826579445173892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.2826579445173892
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.2826579445173892
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.2826579445173892
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.2826579445173892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.2826579445173892
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.2826579445173892
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.2826579445173892
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.2826579445173892
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.2826579445173892
KURU, SUSCEPTIBILITY TO	0.00833333	0.2826579445173892
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.2826579445173892
PLAGUE	0.00833333	0.2826579445173892
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.2826579445173892
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.2826579445173892
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.2826579445173892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.2826579445173892
NOONAN SYNDROME 6; NS6	0.008299504	0.2815106015427025
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00826886	0.28047118872072246
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.008267163	0.2804136282338768
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008267163	0.2804136282338768
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.008267163	0.2804136282338768
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.28027917344904685
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259943	0.28016873329278896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259943	0.28016873329278896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259943	0.28016873329278896
LATERAL MENINGOCELE SYNDROME	0.008255423999999999	0.2800154534813241
CAREY-FINEMAN-ZITER SYNDROME	0.00818825	0.27773698079813375
DISTAL TRISOMY 17Q	0.008182772999999999	0.27755120661636945
AMYLOIDOSIS	0.00816718	0.2770223081653469
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00816718	0.2770223081653469
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008131213	0.2758023446825067
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.2756842049207603
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.275462035687502
MUCOLIPIDOSIS TYPE IV	0.00812118	0.275462035687502
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.2751782356913687
19P13.13 MICRODELETION SYNDROME	0.008107573	0.27500050030476203
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008059214	0.2733602129839771
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.008037443	0.2726217631553866
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.008022569	0.27211725244157214
FEMORAL-FACIAL SYNDROME	0.00802185	0.2720928647043641
MEIER-GORLIN SYNDROME 1; MGORS1	0.00802185	0.2720928647043641
POTOCKI-SHAFFER SYNDROME	0.007991609	0.27106712122604865
OROFACIODIGITAL SYNDROME TYPE 1	0.007991609	0.27106712122604865
OROFACIODIGITAL SYNDROME I; OFD1	0.007991609	0.27106712122604865
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.007983523000000001	0.27079285245961704
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.007983523000000001	0.27079285245961704
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.007983523000000001	0.27079285245961704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.007983523000000001	0.27079285245961704
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007983523000000001	0.27079285245961704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007983523000000001	0.27079285245961704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007983523000000001	0.27079285245961704
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007983523000000001	0.27079285245961704
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007983523000000001	0.27079285245961704
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007983523000000001	0.27079285245961704
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007983523000000001	0.27079285245961704
SALLA DISEASE	0.007983523000000001	0.27079285245961704
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.007970539	0.27035244859326185
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.2697563227498243
300270 ADRENOMYODYSTROPHY	0.007952964	0.2697563227498243
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.2697563227498243
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.26961606782165276
BOWEN-CONRADI SYNDROME	0.007948829	0.26961606782165276
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.26961606782165276
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.26961606782165276
ADRENOMYODYSTROPHY	0.007948829	0.26961606782165276
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.26961606782165276
COG8-CDG	0.007948829	0.26961606782165276
DPM1-CDG	0.007948829	0.26961606782165276
CROME SYNDROME	0.007948829	0.26961606782165276
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.26961606782165276
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.26961606782165276
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.26961606782165276
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.26961606782165276
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.26961606782165276
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.26961606782165276
4Q21 MICRODELETION SYNDROME	0.007948829	0.26961606782165276
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.26961606782165276
LISSENCEPHALY 5; LIS5	0.007948829	0.26961606782165276
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.26961606782165276
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2691982200682925
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2691982200682925
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2691982200682925
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2691982200682925
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2691982200682925
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2691982200682925
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.2691982200682925
184705 STEINFELD SYNDROME	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.2691982200682925
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2691982200682925
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2691982200682925
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2691982200682925
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2691982200682925
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2691982200682925
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2691982200682925
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.2691982200682925
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.2691982200682925
WOLFRAM-LIKE SYNDROME	0.00793651	0.2691982200682925
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.2691982200682925
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2691982200682925
KENNERKNECHT SYNDROME	0.00793651	0.2691982200682925
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.2691982200682925
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2691982200682925
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.2691982200682925
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.2691982200682925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.007926622999999999	0.26886286324245656
POTOCKI-SHAFFER SYNDROME	0.007926622999999999	0.26886286324245656
CK SYNDROME	0.007926622999999999	0.26886286324245656
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.007909748999999999	0.2682905145948227
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00786946	0.2669239533369989
OMODYSPLASIA 1; OMOD1	0.00786946	0.2669239533369989
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00786946	0.2669239533369989
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00786946	0.2669239533369989
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00785773	0.2665260838551485
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00785773	0.2665260838551485
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00785773	0.2665260838551485
LEPRECHAUNISM	0.00785773	0.2665260838551485
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00783091	0.26561637716263103
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00783091	0.26561637716263103
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.007829344	0.26556326006045045
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.007824604	0.2654024841572986
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007824604	0.2654024841572986
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007815084	0.26507957559231854
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.007815084	0.26507957559231854
DUANE RETRACTION SYNDROME	0.007803493	0.2646864208468685
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.2619148003037783
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.2619148003037783
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.2619148003037783
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.2619148003037783
SCARF SYNDROME	0.00770987	0.2615108254078841
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0076720899999999995	0.26022936683803666
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.007669754	0.2601501321313357
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.007669754	0.2601501321313357
TOLUENE EMBRYOPATHY	0.0076413539999999995	0.25918683347110094
FIBULAR HEMIMELIA	0.00762881	0.258761353950186
CHARLIE M SYNDROME	0.007598049999999999	0.25771800652804444
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.25737047279308795
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.25737047279308795
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.25737047279308795
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.25737047279308795
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.25737047279308795
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.25723021786491646
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.25723021786491646
FRIED SYNDROME	0.007578064000000001	0.25704010205538774
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.2566736076179287
THAUVIN-ROBINET-FAIVRE SYNDROME	0.007566154	0.2566361271594935
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.007566154	0.2566361271594935
POTOCKI-LUPSKI SYNDROME	0.0075649229999999994	0.25659437291122766
HYPERTRICHOSIS CUBITI	0.007558934	0.25639123221840565
DISTAL TRISOMY 15Q	0.007554798999999999	0.2562509772902341
ERYTHROKERATODERMIA VARIABILIS	0.00751366	0.2548555849105371
OSTEOGLOSPHONIC DYSPLASIA	0.00751366	0.2548555849105371
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00751366	0.2548555849105371
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.0074960240000000004	0.25425739001011816
SPINOCEREBELLAR ATAXIA 44; SCA44	0.007481150000000001	0.2537528792963037
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.007481150000000001	0.2537528792963037
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.007481150000000001	0.2537528792963037
SPINOCEREBELLAR ATAXIA 13	0.007481150000000001	0.2537528792963037
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.007481150000000001	0.2537528792963037
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.007481150000000001	0.2537528792963037
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.007481150000000001	0.2537528792963037
MULTIPLE METAPHYSEAL DYSPLASIA	0.007462099999999999	0.2531067229766743
OROFACIODIGITAL SYNDROME XVI; OFD16	0.007442104000000001	0.25242847931434853
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007442104000000001	0.25242847931434853
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007442104000000001	0.25242847931434853
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007442104000000001	0.25242847931434853
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.007442104000000001	0.25242847931434853
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007442104000000001	0.25242847931434853
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007437969000000001	0.25228822438617704
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00742912	0.25198807544799334
FACIOCARDIORENAL SYNDROME	0.00742912	0.25198807544799334
TETRASOMY 18P	0.007426069	0.25188458867995195
2Q37 MICRODELETION SYNDROME	0.007409652999999999	0.2513277749191627
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2512516946763843
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2512516946763843
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2512516946763843
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2512516946763843
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2512516946763843
KID SYNDROME	0.00740741	0.2512516946763843
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406243999999999	0.2512121451609676
1Q21.1 MICRODELETION SYNDROME	0.007385632999999999	0.2505130413339923
TETRASOMY 5P	0.007385632999999999	0.2505130413339923
FRONTOOCULAR SYNDROME	0.007385203999999999	0.2504984900971881
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007385203999999999	0.2504984900971881
HADZISELIMOVIC SYNDROME	0.007385203999999999	0.2504984900971881
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.2484602654566189
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007305084	0.24778090246838505
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00728379	0.24705863198701047
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00728379	0.24705863198701047
INTERMEDIATE NEMALINE MYOPATHY	0.0072790500000000005	0.2468978560838586
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0072790500000000005	0.2468978560838586
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0072790500000000005	0.2468978560838586
NEUTRAL LIPID STORAGE MYOPATHY	0.0072790500000000005	0.2468978560838586
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0072790500000000005	0.2468978560838586
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0072790500000000005	0.2468978560838586
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0072790500000000005	0.2468978560838586
ALAGILLE SYNDROME	0.00726953	0.2465749475188785
CENANI-LENZ SYNDROME	0.00726953	0.2465749475188785
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00726953	0.2465749475188785
CINCA SYNDROME	0.007267633999999999	0.24651063715761778
ABRUZZO-ERICKSON SYNDROME	0.007264729999999999	0.24641213647771204
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.007264729999999999	0.24641213647771204
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.2463703822294463
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.24616724153662425
RING CHROMOSOME 13 SYNDROME	0.0071801899999999995	0.24354462701516827
RING CHROMOSOME 6 SYNDROME	0.0071801899999999995	0.24354462701516827
STROMME SYNDROME; STROMS	0.00717297	0.24329973207408045
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.24329973207408045
WAARDENBURG-SHAH SYNDROME	0.00717297	0.24329973207408045
WAARDENBURG SYNDROME	0.00717297	0.24329973207408045
ADULT SYNDROME	0.00717297	0.24329973207408045
DONNAI-BARROW SYNDROME	0.007165523	0.24304713752750412
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0071242	0.2416455040578957
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.0071242	0.2416455040578957
TREACHER COLLINS SYNDROME 3; TCS3	0.0071242	0.2416455040578957
TREACHER COLLINS SYNDROME 2; TCS2	0.0071242	0.2416455040578957
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0071242	0.2416455040578957
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0071242	0.2416455040578957
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.007095799999999999	0.24068220539766094
PTERYGIUM COLLI, ISOLATED	0.007095799999999999	0.24068220539766094
OROFACIAL CLEFT 15	0.007095799999999999	0.24068220539766094
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.23886584471964795
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.23886584471964795
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.23886584471964795
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.23886584471964795
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.23886584471964795
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.23886584471964795
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.23886584471964795
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.23886584471964795
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.23886584471964795
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.23886584471964795
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.23886584471964795
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.23886584471964795
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.23886584471964795
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.23886584471964795
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.2382299997659592
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019369	0.23808974483778772
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013808999999999	0.2379011553817699
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.23788660414496565
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.23788660414496565
BARDET-BIEDL SYNDROME	0.00701338	0.23788660414496565
SECKEL SYNDROME 5; SCKL5	0.00701338	0.23788660414496565
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.23788660414496565
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.236625496955264
ISOLATED CLEFT LIP	0.006976199999999999	0.236625496955264
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.236625496955264
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00697529	0.23659463069537623
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00695047	0.23575276193667813
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00689655	0.23392385124090853
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00689655	0.23392385124090853
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00689655	0.23392385124090853
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00689655	0.23392385124090853
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.00689655	0.23392385124090853
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00689655	0.23392385124090853
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888193000000001	0.23364039043444443
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00688465	0.2335202155346834
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.006876283	0.23323641553855018
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.23296340177389419
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.23296340177389419
ADAMS-OLIVER SYNDROME 5; AOS5	0.0068640989999999985	0.23282314684572267
LOEYS-DIETZ SYNDROME 5	0.00686069	0.23270751708752763
MILLER-DIEKER SYNDROME	0.006845639000000001	0.23219700271657015
CEREBROOCULONASAL SYNDROME	0.006839649999999999	0.23199386202374808
BALLER-GEROLD SYNDROME	0.006839649999999999	0.23199386202374808
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23009589231135041
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.22995563738317887
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00673116	0.22831399330371763
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00673116	0.22831399330371763
JOUBERT SYNDROME 24	0.006696534	0.22713951515550326
EHLERS-DANLOS SYNDROME, TYPE VI	0.00668696	0.22681477496631006
COSTELLO SYNDROME; CSTLO	0.006684624	0.22673554025960907
DISTAL MONOSOMY 6P	0.006684624	0.22673554025960907
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184	0.22617791244361404
15Q OVERGROWTH SYNDROME	0.006664049	0.22603765751544255
KABUKI SYNDROME 1	0.006635843000000001	0.22508093913478833
MICRO SYNDROME	0.006635843000000001	0.22508093913478833
2Q31.1 MICRODELETION SYNDROME	0.006572523	0.22293319015006777
WALKER-WARBURG SYNDROME	0.0065514530000000005	0.22221851751728097
ADAMS-OLIVER SYNDROME 2; AOS2	0.0065514530000000005	0.22221851751728097
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.006487983000000001	0.220065680687524
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.0064762529999999995	0.21966781120567347
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.006450374	0.21879002226101807
ICF SYNDROME	0.006450374	0.21879002226101807
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.006450374	0.21879002226101807
FANCONI ANEMIA	0.006450373999999999	0.21879002226101804
DISTAL MONOSOMY 3P	0.0064462389999999994	0.21864976733284655
KAGAMI-OGATA SYNDROME	0.006406123	0.2172890740562981
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.006406123	0.2172890740562981
WILSON-TURNER SYNDROME	0.006406123	0.2172890740562981
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006406123	0.2172890740562981
PALLISTER-HALL SYNDROME	0.006406123	0.2172890740562981
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.006366759999999999	0.2159539217618326
BASAL CELL NEVUS SYNDROME	0.006366759999999999	0.2159539217618326
ELSAHY-WATERS SYNDROME; ESWS	0.0063644240000000005	0.21587468705513163
3C SYNDROME	0.0063644240000000005	0.21587468705513163
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.21513576236100443
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.006295303	0.2135301741433681
MEND SYNDROME; MEND	0.006295303	0.2135301741433681
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.006295303	0.2135301741433681
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.006295303	0.2135301741433681
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.006295303	0.2135301741433681
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.006295303	0.2135301741433681
MEND SYNDROME	0.006295303	0.2135301741433681
DISTAL 16P11.2 MICRODELETION SYNDROME	0.006295303	0.2135301741433681
15Q14 MICRODELETION SYNDROME	0.006295303	0.2135301741433681
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21159126423791041
FRASER SYNDROME	0.00623814	0.21159126423791041
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21159126423791041
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006215183000000001	0.21081258651456505
PETTIGREW SYNDROME	0.006215183000000001	0.21081258651456505
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.006215183000000001	0.21081258651456505
XQ21 MICRODELETION SYNDROME	0.006215183000000001	0.21081258651456505
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183	0.21081258651456505
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.006178964	0.2095840754520636
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006166573	0.20916378553308582
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.20863488708206332
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.20863488708206332
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.20863488708206332
MIRAGE SYNDROME; MIRAGE	0.006142613	0.20835108708593003
CHROMOSOME 18P DELETION SYNDROME	0.006094424	0.20671656598951982
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0060902890000000005	0.20657631106134833
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.20617813630879558
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.006013083000000001	0.20395756330212006
AICARDI-GOUTIÈRES SYNDROME	0.006013083000000001	0.20395756330212006
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006013083	0.20395756330212003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.006013083	0.20395756330212003
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.006013083	0.20395756330212003
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.006010034	0.20385414437201244
CHAR SYNDROME	0.006010034	0.20385414437201244
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006010034	0.20385414437201244
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.006010034	0.20385414437201244
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.006010034	0.20385414437201244
BRESEK SYNDROME	0.006010034	0.20385414437201244
HARROD SYNDROME	0.006005899	0.20371388944384095
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.006005899	0.20371388944384095
16Q24.3 MICRODELETION SYNDROME	0.006005899	0.20371388944384095
FRAGILE X SYNDROME	0.006005899	0.20371388944384095
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0059489	0.20178054224895647
OPITZ G/BBB SYNDROME	0.0059465640000000005	0.20170130754225546
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0059465640000000005	0.20170130754225546
JOUBERT SYNDROME 10	0.0059465640000000005	0.20170130754225546
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00593717	0.201382672767106
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00593717	0.201382672767106
PROTEUS SYNDROME	0.005930699	0.2011631831322335
PROGEROID SYNDROME, PETTY TYPE	0.00590482	0.20028539418757807
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00590482	0.20028539418757807
RING CHROMOSOME 12 SYNDROME	0.005864704	0.1989247009110296
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005864704	0.1989247009110296
MEIER-GORLIN SYNDROME 7	0.005864704	0.1989247009110296
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.005864704	0.1989247009110296
EVEN-PLUS SYNDROME	0.005864704	0.1989247009110296
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.005864704	0.1989247009110296
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0058605689999999995	0.1987844459828581
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0058605689999999995	0.1987844459828581
3-HYDROXYISOBUTYRIC ACIDURIA	0.0058605689999999995	0.1987844459828581
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.19804786169744762
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00581887	0.19737005898169163
CRANIOFRONTONASAL DYSPLASIA	0.00581887	0.19737005898169163
GENITOPALATOCARDIAC SYNDROME	0.00581887	0.19737005898169163
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19677138921573592
BEHR SYNDROME	0.00580122	0.19677138921573592
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19677138921573592
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19677138921573592
DYSTONIA 16; DYT16	0.00580122	0.19677138921573592
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19677138921573592
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19677138921573592
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19677138921573592
MAST SYNDROME	0.00580122	0.19677138921573592
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0057611039999999995	0.19541069593918742
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057611039999999995	0.19541069593918742
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0057598729999999996	0.19536894169092162
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0057598729999999996	0.19536894169092162
CENTRAL BILATERAL MACROGYRIA	0.0057598729999999996	0.19536894169092162
SEVERE CANAVAN DISEASE	0.0057598729999999996	0.19536894169092162
CANAVAN DISEASE	0.0057598729999999996	0.19536894169092162
VICI SYNDROME	0.0057598729999999996	0.19536894169092162
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0057598729999999996	0.19536894169092162
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0057598729999999996	0.19536894169092162
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0057598729999999996	0.19536894169092162
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.0057598729999999996	0.19536894169092162
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.0057598729999999996	0.19536894169092162
HARTNUP DISEASE	0.0057598729999999996	0.19536894169092162
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0057598729999999996	0.19536894169092162
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0057598729999999996	0.19536894169092162
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0057598729999999996	0.19536894169092162
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0057598729999999996	0.19536894169092162
TAY-SACHS DISEASE	0.0057598729999999996	0.19536894169092162
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0057598729999999996	0.19536894169092162
SCHIZENCEPHALY	0.0057598729999999996	0.19536894169092162
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.19536894169092162
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.005756969000000001	0.19527044101101595
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.19516580099809958
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.19516580099809958
DISTAL TRISOMY 18Q	0.005753884	0.19516580099809958
12Q14 MICRODELETION SYNDROME	0.005753884	0.19516580099809958
ALAZAMI-YUAN SYNDROME	0.005753884	0.19516580099809958
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.19516580099809958
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.19502554606992809
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.19244821336929657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.005673764	0.19244821336929657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005673764	0.19244821336929657
MARINESCO-SJOGREN SYNDROME; MSS	0.005673764	0.19244821336929657
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.19244821336929657
SPINOCEREBELLAR ATAXIA 5; SCA5	0.005673764	0.19244821336929657
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.19230795844112508
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.005669629000000001	0.19230795844112508
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005669629000000001	0.19230795844112508
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.19230795844112508
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.19230795844112508
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005669629000000001	0.19230795844112508
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.005669629000000001	0.19230795844112508
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.005669629000000001	0.19230795844112508
HUNTINGTON DISEASE; HD	0.005669629000000001	0.19230795844112508
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047403
GORLIN SYNDROME	0.00564514	0.19147731686047403
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047403
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.19147731686047403
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.19147731686047403
SAUL-WILSON SYNDROME; SWILS	0.005601194	0.18998671394066155
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005601194	0.18998671394066155
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.18984645901249003
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00554887	0.1882119379160798
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00554887	0.1882119379160798
SHORT SYNDROME	0.00554887	0.1882119379160798
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00554887	0.1882119379160798
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00554887	0.1882119379160798
LERI PLEONOSTEOSIS	0.00549746	0.18646816382725348
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.18646816382725348
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.18646816382725348
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.0054855500000000005	0.1860641889313593
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005471664	0.18559319015685155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.005471664	0.18559319015685155
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.005471664	0.18559319015685155
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.005471664	0.18559319015685155
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.005471664	0.18559319015685155
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0054675290000000005	0.18545293522868006
SECONDARY SYRINGOMYELIA	0.0054675290000000005	0.18545293522868006
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00546448	0.18534951629857244
LIMB-MAMMARY SYNDROME	0.00546448	0.18534951629857244
BLOOM SYNDROME	0.00546448	0.18534951629857244
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00546448	0.18534951629857244
WOODHOUSE-SAKATI SYNDROME	0.00546448	0.18534951629857244
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00546448	0.18534951629857244
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00546448	0.18534951629857244
WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	0.00546448	0.18534951629857244
3M SYNDROME	0.00546448	0.18534951629857244
CRANIOECTODERMAL DYSPLASIA 4	0.00546448	0.18534951629857244
WEAVER-WILLIAMS SYNDROME	0.00546448	0.18534951629857244
SCHIZOPHRENIA 1; SCZD1	0.00546448	0.18534951629857244
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00546448	0.18534951629857244
RODRIGUES BLINDNESS	0.00546448	0.18534951629857244
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00546448	0.18534951629857244
THREE M SYNDROME 2; 3M2	0.00546448	0.18534951629857244
TRISOMY 5P	0.00546448	0.18534951629857244
BLOOM SYNDROME	0.00546448	0.18534951629857244
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00546448	0.18534951629857244
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420992999999999	0.18387448218457142
49,XXXXY SYNDROME	0.005420992999999999	0.18387448218457142
48,XXXY SYNDROME	0.005420992999999999	0.18387448218457142
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420992999999999	0.18387448218457142
8P11.2 DELETION SYNDROME	0.005420992999999999	0.18387448218457142
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.18360065436470968
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00540101	0.1831966794688155
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.0054010099999999995	0.18319667946881543
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00538928	0.182798809986965
SIALIDOSIS TYPE 2	0.005360472999999999	0.18182170630719802
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.18182170630719802
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.18182170630719802
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.18182170630719802
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.18182170630719802
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.18182170630719802
HEMIFACIAL MICROSOMIA	0.00531915	0.1804200728375896
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00531915	0.1804200728375896
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00531915	0.1804200728375896
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00531915	0.1804200728375896
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00531915	0.1804200728375896
MICROTIA - EYE COLOBOMA - IMPERFORATION OF THE NASOLACRIMAL DUCT	0.00531915	0.1804200728375896
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00531915	0.1804200728375896
CHANARIN-DORFMAN SYNDROME	0.00531915	0.1804200728375896
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00531915	0.1804200728375896
DIABETIC EMBRYOPATHY	0.00531915	0.1804200728375896
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00531915	0.1804200728375896
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00531915	0.1804200728375896
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00531915	0.1804200728375896
COXOAURICULAR SYNDROME	0.00531915	0.1804200728375896
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00531915	0.1804200728375896
MEIER-GORLIN SYNDROME 8; MGORS8	0.00531915	0.1804200728375896
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00531915	0.1804200728375896
COXOAURICULAR SYNDROME	0.00531915	0.1804200728375896
MICROTIA-ANOTIA	0.00531915	0.1804200728375896
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00531915	0.1804200728375896
OCULOAURICULOFRONTONASAL SYNDROME	0.00531915	0.1804200728375896
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.00531915	0.1804200728375896
DISTAL MONOSOMY 17Q	0.00531915	0.1804200728375896
MEIER-GORLIN SYNDROME 2; MGORS2	0.00531915	0.1804200728375896
HAND-FOOT-GENITAL SYNDROME	0.00531915	0.1804200728375896
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00531915	0.1804200728375896
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00531915	0.1804200728375896
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00531915	0.1804200728375896
OTOMANDIBULAR SYNDROME	0.00531915	0.1804200728375896
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.00531915	0.1804200728375896
ISOLATED ARRHINIA	0.00531915	0.1804200728375896
ISOTRETINOIN SYNDROME	0.00531915	0.1804200728375896
DIAMOND-BLACKFAN ANEMIA 10	0.00531915	0.1804200728375896
GOLDENHAR SYNDROME	0.00531915	0.1804200728375896
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00531915	0.1804200728375896
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.17790372643946167
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.1770045685456531
ACHALASIA-MICROCEPHALY SYNDROME	0.005215549999999999	0.1769060678657474
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.005215549999999999	0.1769060678657474
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.17686431361748162
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.17686431361748162
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.17686431361748162
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.17686431361748162
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.17686431361748162
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.17686431361748162
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.17686431361748162
AUTISM	0.005214319	0.17686431361748162
BANGSTAD SYNDROME	0.005214319	0.17686431361748162
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.17686431361748162
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.17686431361748162
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.17686431361748162
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.17686431361748162
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.17686431361748162
XERODERMA PIGMENTOSUM	0.005214319	0.17686431361748162
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.17686431361748162
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.17686431361748162
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.17686431361748162
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.17686431361748162
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748162
KRABBE DISEASE	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.17686431361748162
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.17686431361748162
EPILEPSY, READING	0.005214319	0.17686431361748162
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.17686431361748162
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.17686431361748162
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.17686431361748162
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.17686431361748162
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.17686431361748162
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.17686431361748162
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.17666117292465958
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.17666117292465958
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.17666117292465958
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.17666117292465958
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.17666117292465958
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.17666117292465958
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.17666117292465958
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.17394358529585657
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 28	0.00512821	0.17394358529585657
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 14	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 23	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 18	0.00512821	0.17394358529585657
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.17394358529585657
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 25	0.00512821	0.17394358529585657
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 2	0.00512821	0.17394358529585657
MULTIPLE SYSTEM ATROPHY	0.00512821	0.17394358529585657
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00512821	0.17394358529585657
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.17394358529585657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.17394358529585657
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00512821	0.17394358529585657
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 14	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00512821	0.17394358529585657
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 15	0.00512821	0.17394358529585657
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00512821	0.17394358529585657
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.17394358529585657
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 26	0.00512821	0.17394358529585657
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.17394358529585657
SUSAC SYNDROME	0.00512821	0.17394358529585657
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00512821	0.17394358529585657
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00512821	0.17394358529585657
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA TYPE 30	0.00512821	0.17394358529585657
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00512821	0.17394358529585657
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 31	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00512821	0.17394358529585657
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00512821	0.17394358529585657
BOUCHER-NEUHAUSER SYNDROME	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.17394358529585657
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 20	0.00512821	0.17394358529585657
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00512821	0.17394358529585657
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00512821	0.17394358529585657
ARNOLD-CHIARI MALFORMATION TYPE I	0.00512821	0.17394358529585657
MYOTONIA PERMANENS	0.0050796	0.1722947843143773
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.17148208586722155
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.17148208586722155
CENTRAL CORE DISEASE	0.00505564	0.17148208586722155
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.16767973575768025
MUENKE SYNDROME	0.004941203	0.16760050105097923
RUVALCABA SYNDROME	0.004941203	0.16760050105097923
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00492611	0.16708856208341155
CONGENITAL PATELLA DISLOCATION	0.00492611	0.16708856208341155
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00492611	0.16708856208341155
IMMUNODEFICIENCY 9; IMD9	0.00492611	0.16708856208341155
SPINOCEREBELLAR ATAXIA TYPE 36	0.00492611	0.16708856208341155
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.00492611	0.16708856208341155
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00492611	0.16708856208341155
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00492611	0.16708856208341155
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.00492611	0.16708856208341155
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00492611	0.16708856208341155
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00492611	0.16708856208341155
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00492611	0.16708856208341155
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00492611	0.16708856208341155
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.00492611	0.16708856208341155
POSTERIOR MENINGOCELE	0.00492611	0.16708856208341155
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00492611	0.16708856208341155
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.00492611	0.16708856208341155
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.00492611	0.16708856208341155
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00492611	0.16708856208341155
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00492611	0.16708856208341155
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00492611	0.16708856208341155
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00492611	0.16708856208341155
WILSON DISEASE	0.00492611	0.16708856208341155
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00492611	0.16708856208341155
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00492611	0.16708856208341155
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00492611	0.16708856208341155
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00492611	0.16708856208341155
PRIMARY DYSTONIA, DYT2 TYPE	0.00492611	0.16708856208341155
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00492611	0.16708856208341155
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00492611	0.16708856208341155
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00492611	0.16708856208341155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00492611	0.16708856208341155
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00492611	0.16708856208341155
ADULT-ONSET NEMALINE MYOPATHY	0.00492611	0.16708856208341155
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00492611	0.16708856208341155
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00492611	0.16708856208341155
DIAPHANOSPONDYLODYSOSTOSIS	0.004879573999999999	0.16551010903930297
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.16551010903930297
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.16551010903930297
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875439	0.16536985411113148
MARDEN-WALKER SYNDROME	0.004875438999999999	0.16536985411113142
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.16495248122330794
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858998999999999	0.16481222629513642
COG5-CDG	0.004858998999999999	0.16481222629513642
ZTTK SYNDROME; ZTTKS	0.004856663000000001	0.1647329915884355
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663000000001	0.1647329915884355
3Q29 MICRODUPLICATION SYNDROME	0.004856663000000001	0.1647329915884355
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663000000001	0.1647329915884355
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192954
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192954
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.16345733316192954
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192954
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.16345733316192954
CONGENITAL HYPOTHYROIDISM	0.004819054	0.16345733316192954
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.16345733316192954
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.16345733316192954
THYROID ECTOPIA	0.004819054	0.16345733316192954
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.16345733316192954
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.16345733316192954
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.16345733316192954
THYROID HEMIAGENESIS	0.004819054	0.16345733316192954
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.16331707823375802
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.16331707823375802
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.16331707823375802
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.16331707823375802
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.16331707823375802
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.16117886047873914
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.16117886047873914
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.16117886047873914
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.16117886047873914
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.16117886047873914
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.16117886047873914
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.16117886047873914
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.16117886047873914
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.16117886047873914
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.16117886047873914
ATELOSTEOGENESIS TYPE I	0.00475188	0.16117886047873914
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.16117886047873914
CONGENITAL HYDROCEPHALUS	0.004699409	0.15939909836602167
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.15939909836602167
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.15939909836602167
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.15939909836602167
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.004682933	0.1588402494672179
C SYNDROME	0.004682933	0.1588402494672179
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.1588402494672179
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.1588402494672179
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.1588402494672179
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.1588402494672179
SIALURIA	0.004682933	0.1588402494672179
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.1588402494672179
COFFIN-SIRIS SYNDROME	0.004682933	0.1588402494672179
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.1584999404722131
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.1584999404722131
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.1584999404722131
ISAAC SYNDROME	0.0046729	0.1584999404722131
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.1584999404722131
ARGININOSUCCINIC ACIDURIA	0.0046729	0.1584999404722131
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.1584999404722131
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.1584999404722131
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.1584999404722131
SACCHAROPINURIA	0.0046729	0.1584999404722131
SCHIZOPHRENIA	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.1584999404722131
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0046712030000000005	0.15844237998536742
KBG SYNDROME	0.0046712030000000005	0.15844237998536742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0046712030000000005	0.15844237998536742
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0046712030000000005	0.15844237998536742
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.0046712030000000005	0.15844237998536742
SSR4-CDG	0.0046712030000000005	0.15844237998536742
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536742
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536742
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0046712030000000005	0.15844237998536742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0046712030000000005	0.15844237998536742
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0046712030000000005	0.15844237998536742
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0046712030000000005	0.15844237998536742
HOLOPROSENCEPHALY 7	0.0046712030000000005	0.15844237998536742
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004671203	0.1584423799853674
MACDERMOT-WINTER SYNDROME	0.004671203	0.1584423799853674
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004671203	0.1584423799853674
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004671203	0.1584423799853674
11P15.4 MICRODUPLICATION SYNDROME	0.004671203	0.1584423799853674
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004671203	0.1584423799853674
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.004671203	0.1584423799853674
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.15831135101619534
FLOATING-HARBOR SYNDROME	0.004559374	0.15464925583482553
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555238999999999	0.154509000906654
L1 SYNDROME	0.0045352529999999995	0.15383109643399728
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0045352529999999995	0.15383109643399728
NIEMANN-PICK DISEASE TYPE C	0.0045352529999999995	0.15383109643399728
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0045352529999999995	0.15383109643399728
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0045352529999999995	0.15383109643399728
FOIX-CHAVANY-MARIE SYNDROME	0.0045352529999999995	0.15383109643399728
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0045352529999999995	0.15383109643399728
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0045352529999999995	0.15383109643399728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0045352529999999995	0.15383109643399728
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0045352529999999995	0.15383109643399728
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0045352529999999995	0.15383109643399728
16P13.2 MICRODELETION SYNDROME	0.0045352529999999995	0.15383109643399728
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004529814	0.1536466111729756
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004523343000000001	0.15342712153810312
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.004523343000000001	0.15342712153810312
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004523343000000001	0.15342712153810312
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004523343000000001	0.15342712153810312
15Q11Q13 MICRODUPLICATION SYNDROME	0.004523343	0.1534271215381031
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004523343	0.1534271215381031
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.15289822308708054
LARON SYNDROME	0.00440212	0.14931536261241174
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.14931536261241174
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.14931536261241174
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.14931536261241174
OCCIPITAL HORN SYNDROME	0.004399784	0.14923612790571078
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.14909587297753923
THANATOPHORIC DYSPLASIA	0.004395649	0.14909587297753923
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.14909587297753923
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.14700548096586297
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.004334019999999999	0.14700548096586297
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.004334019999999999	0.14700548096586297
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.004334019999999999	0.14700548096586297
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.14644785314986794
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.14644785314986794
HEREDITARY OROTIC ACIDURIA	0.004315244	0.14636861844316695
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.14622836351499546
GAPO SYNDROME	0.0042734999999999995	0.1449527050884895
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1449527050884895
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1449527050884895
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1449527050884895
COOPER-JABS SYNDROME	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1449527050884895
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.1449527050884895
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1449527050884895
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1449527050884895
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1449527050884895
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.1449527050884895
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1449527050884895
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1449527050884895
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS	0.0042734999999999995	0.1449527050884895
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.1449527050884895
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.1449527050884895
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.1449527050884895
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.1449527050884895
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.1449527050884895
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1449527050884895
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.1449527050884895
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.1449527050884895
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.1449527050884895
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.1449527050884895
BLADDER EXSTROPHY	0.0042734999999999995	0.1449527050884895
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.1449527050884895
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.1449527050884895
OROFACIODIGITAL SYNDROME VI	0.004226054	0.14334338578449318
TETRASOMY X	0.004226054	0.14334338578449318
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.14334338578449318
BARATELA-SCOTT SYNDROME	0.004226054	0.14334338578449318
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.14320313085632164
SOTOS SYNDROME 2	0.00415799	0.14103472522075317
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.14103472522075317
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.14103472522075317
8Q12 MICRODUPLICATION SYNDROME	0.004141514000000001	0.1404758763219494
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514	0.14047587632194938
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514	0.14047587632194938
LIG4 SYNDROME	0.004141514	0.14047587632194938
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004141514	0.14047587632194938
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514	0.14047587632194938
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004137379	0.1403356213937779
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004137379	0.1403356213937779
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.004129784	0.1400780068400989
MENTAL RETARDATION, X-LINKED 107; MRX107	0.004129784	0.1400780068400989
HOLOPROSENCEPHALY 5; HPE5	0.004129784	0.1400780068400989
HYPOTONIA-CYSTINURIA SYNDROME	0.004129784	0.1400780068400989
OPTIC ATROPHY 11; OPA11	0.004129784	0.1400780068400989
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004129784	0.1400780068400989
ARTERIAL TORTUOSITY SYNDROME	0.004129784	0.1400780068400989
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004125649	0.13993775191192742
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.004125649	0.13993775191192742
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.004125649	0.13993775191192742
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.004125649	0.13993775191192742
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.004125649	0.13993775191192742
WARBURG MICRO SYNDROME 3; WARBM3	0.004125649	0.13993775191192742
FRAGILE X MENTAL RETARDATION SYNDROME	0.004125649	0.13993775191192742
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.13614462776138553
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.13614462776138553
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.13614462776138553
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.13614462776138553
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.13614462776138553
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.13614462776138553
SHORT SYNDROME	0.0040138199999999995	0.13614462776138553
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.13614462776138553
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.13614462776138553
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.13614462776138553
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.13614462776138553
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.1354667232887288
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.1354667232887288
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.1354667232887288
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.1354667232887288
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.1354667232887288
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.1354667232887288
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.1354667232887288
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.1354667232887288
RIDDLE SYNDROME	0.003993834	0.1354667232887288
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.1354667232887288
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.1354667232887288
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.1354667232887288
BEHÇET DISEASE	0.003989699	0.1353264683605573
KALLMANN SYNDROME	0.003989699	0.1353264683605573
ALZHEIMER DISEASE 3; AD	0.003989699	0.1353264683605573
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.1353264683605573
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.1353264683605573
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.1353264683605573
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.1353264683605573
SUBEPENDYMOMA	0.003989699	0.1353264683605573
EPENDYMOMA	0.003989699	0.1353264683605573
ATAXIA-TELANGIECTASIA	0.003989699	0.1353264683605573
KUFOR-RAKEB SYNDROME	0.003989699	0.1353264683605573
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.1353264683605573
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.1353264683605573
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.1353264683605573
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.1353264683605573
CENTRONUCLEAR MYOPATHY	0.003989699	0.1353264683605573
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.1353264683605573
DYSEQUILIBRIUM SYNDROME	0.003989699	0.1353264683605573
TENORIO SYNDROME; TNORS	0.003989699	0.1353264683605573
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.1353264683605573
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.1353264683605573
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.1353264683605573
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.1353264683605573
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.1353264683605573
LYNCH SYNDROME	0.003989699	0.1353264683605573
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00398426	0.1351419830995356
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00398426	0.1351419830995356
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.003981924	0.1350627483928346
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003981924	0.1350627483928346
CUTIS LAXA	0.003981924	0.1350627483928346
NOONAN SYNDROME 5; NS5	0.003981924	0.1350627483928346
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.003981924	0.1350627483928346
NOONAN SYNDROME 3; NS3	0.003981924	0.1350627483928346
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.13073149983227075
FIBROCHONDROGENESIS	0.00385423	0.13073149983227075
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.13073149983227075
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.13073149983227075
1Q21.1 MICRODUPLICATION SYNDROME	0.003789673	0.12854179308548297
DISTAL MONOSOMY 15Q	0.003789673	0.12854179308548297
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.003789673	0.12854179308548297
ACROMELIC FRONTONASAL DYSPLASIA	0.003789673	0.12854179308548297
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0037896729999999995	0.12854179308548294
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.12786399036972695
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.12786399036972695
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.12786399036972695
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.12786399036972695
RING CHROMOSOME 1 SYNDROME	0.00376969	0.12786399036972695
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.12786399036972695
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.12786399036972695
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.12786399036972695
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.12786399036972695
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.12483875771105318
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0036804999999999997	0.12483875771105318
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.12483875771105318
JACOBSEN SYNDROME	0.0036804999999999997	0.12483875771105318
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.12483875771105318
SILLENCE SYNDROME	0.0036804999999999997	0.12483875771105318
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.12483875771105318
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.12483875771105318
CRANIOECTODERMAL DYSPLASIA	0.0036804999999999997	0.12483875771105318
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.12483875771105318
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.12483875771105318
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.12483875771105318
SUMMITT SYNDROME	0.0036804999999999997	0.12483875771105318
FRONTORHINY	0.0036804999999999997	0.12483875771105318
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.0036804999999999997	0.12483875771105318
VELO-FACIAL-SKELETAL SYNDROME	0.00359596	0.1219712482485094
3Q13 MICRODELETION SYNDROME	0.00359596	0.1219712482485094
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.1219712482485094
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.1219712482485094
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.1219712482485094
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.1219712482485094
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.1219712482485094
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00358423	0.12157337876665891
ATKIN-FLAITZ SYNDROME	0.00358423	0.12157337876665891
SAY SYNDROME	0.00358423	0.12157337876665891
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00358423	0.12157337876665891
WARBURG MICRO SYNDROME 1	0.00358423	0.12157337876665891
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00358423	0.12157337876665891
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00358423	0.12157337876665891
DERMATOLEUKODYSTROPHY	0.00358423	0.12157337876665891
LAMBOTTE SYNDROME	0.00358423	0.12157337876665891
THAKKER-DONNAI SYNDROME	0.00358423	0.12157337876665891
NIJMEGEN BREAKAGE SYNDROME	0.00358423	0.12157337876665891
HOLZGREVE SYNDROME	0.00358423	0.12157337876665891
NAKAJO-NISHIMURA SYNDROME	0.00358423	0.12157337876665891
601095 HARROD SYNDROME	0.00358423	0.12157337876665891
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00358423	0.12157337876665891
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00358423	0.12157337876665891
NEU-LAXOVA SYNDROME	0.00358423	0.12157337876665891
SOMATOMAMMOTROPINOMA	0.00358423	0.12157337876665891
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00358423	0.12157337876665891
ALAGILLE SYNDROME 1; ALGS1	0.00358423	0.12157337876665891
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00358423	0.12157337876665891
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00358423	0.12157337876665891
ACROMEGALY	0.00358423	0.12157337876665891
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11696209521528882
PSEUDOACHONDROPLASIA	0.00344828	0.11696209521528882
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528882
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528882
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11696209521528882
CLASSIC GALACTOSEMIA	0.00344828	0.11696209521528882
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11696209521528882
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11696209521528882
POLYMYOSITIS	0.00344828	0.11696209521528882
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11696209521528882
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11696209521528882
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11696209521528882
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11696209521528882
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11696209521528882
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11696209521528882
DYSTONIA 23; DYT23	0.00344828	0.11696209521528882
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11696209521528882
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11696209521528882
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11696209521528882
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11696209521528882
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11696209521528882
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11696209521528882
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11696209521528882
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11696209521528882
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11696209521528882
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11696209521528882
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11696209521528882
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11696209521528882
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11696209521528882
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11696209521528882
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11696209521528882
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11696209521528882
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11696209521528882
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11696209521528882
BENIGN HEREDITARY CHOREA	0.00344828	0.11696209521528882
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11696209521528882
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11696209521528882
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11696209521528882
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11696209521528882
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11696209521528882
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11696209521528882
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11696209521528882
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11696209521528882
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11696209521528882
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11696209521528882
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11696209521528882
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11696209521528882
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11696209521528882
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11696209521528882
THORACOMELIC DYSPLASIA	0.00344828	0.11696209521528882
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11696209521528882
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11696209521528882
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11696209521528882
CYSTINOSIS	0.00344828	0.11696209521528882
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11696209521528882
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11696209521528882
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11696209521528882
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11696209521528882
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11696209521528882
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11696209521528882
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11696209521528882
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11696209521528882
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11696209521528882
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11696209521528882
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11696209521528882
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11696209521528882
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11696209521528882
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11696209521528882
KENNEDY DISEASE	0.00344828	0.11696209521528882
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11696209521528882
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11696209521528882
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11696209521528882
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11696209521528882
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11696209521528882
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11696209521528882
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11696209521528882
NONAKA MYOPATHY	0.00344828	0.11696209521528882
NEMALINE MYOPATHY 6	0.00344828	0.11696209521528882
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11696209521528882
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11696209521528882
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11696209521528882
MANGANESE POISONING	0.00344828	0.11696209521528882
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11696209521528882
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11696209521528882
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11696209521528882
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11696209521528882
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11696209521528882
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11696209521528882
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11696209521528882
MASA SYNDROME	0.00344828	0.11696209521528882
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11696209521528882
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11696209521528882
ROUSSY-LÉVY SYNDROME	0.00344828	0.11696209521528882
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11696209521528882
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11696209521528882
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11696209521528882
SPONASTRIME DYSPLASIA	0.00344828	0.11696209521528882
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11696209521528882
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11696209521528882
MYOTONIA FLUCTUANS	0.00344828	0.11696209521528882
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11696209521528882
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11696209521528882
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11696209521528882
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.0034399129999999997	0.11667829521915556
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0034399129999999997	0.11667829521915556
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0034399129999999997	0.11667829521915556
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0034399129999999997	0.11667829521915556
KETOADIPICACIDURIA	0.0034399129999999997	0.11667829521915556
VICI SYNDROME; VICIS	0.0034399129999999997	0.11667829521915556
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0034399129999999997	0.11667829521915556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.0034399129999999997	0.11667829521915556
PRADER-WILLI SYNDROME; PWS	0.0034399129999999997	0.11667829521915556
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0034363700000000002	0.1165581203193946
NOONAN SYNDROME 8; NS8	0.0034363700000000002	0.1165581203193946
DIAMOND-BLACKFAN ANEMIA 1	0.0034363700000000002	0.1165581203193946
8Q21.11 MICRODELETION SYNDROME	0.0034363700000000002	0.1165581203193946
GMS SYNDROME	0.0034363700000000002	0.1165581203193946
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0034363700000000002	0.1165581203193946
LEGIUS SYNDROME	0.0034363700000000002	0.1165581203193946
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0034363700000000002	0.1165581203193946
ACRORENAL-MANDIBULAR SYNDROME	0.0034363700000000002	0.1165581203193946
NOONAN SYNDROME 4; NS4	0.0034363700000000002	0.1165581203193946
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11017741994021446
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11017741994021446
RAHMAN SYNDROME	0.003248254	0.11017741994021446
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11017741994021446
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11017741994021446
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11017741994021446
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11017741994021446
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11017741994021446
LARSEN-LIKE SYNDROME	0.003248254	0.11017741994021446
ATELOSTEOGENESIS TYPE III	0.003248254	0.11017741994021446
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11017741994021446
MOSAIC TRISOMY 9	0.003248254	0.11017741994021446
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.11003716501204297
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.11003716501204297
CYSTATHIONINURIA	0.0032441189999999997	0.11003716501204297
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.11003716501204297
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.11003716501204297
GRACILE BONE DYSPLASIA; GCLEB	0.0031361529999999996	0.10637506983067314
COWDEN SYNDROME	0.0031361529999999996	0.10637506983067314
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0031361529999999996	0.10637506983067314
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0031361529999999996	0.10637506983067314
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0030516130000000003	0.10350756036812939
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0030516130000000003	0.10350756036812939
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030516130000000003	0.10350756036812939
CHROMOSOME 1P35 DELETION SYNDROME	0.0030516130000000003	0.10350756036812939
BOHRING-OPITZ SYNDROME	0.0030516130000000003	0.10350756036812939
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0030516130000000003	0.10350756036812939
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0030516130000000003	0.10350756036812939
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.0030516130000000003	0.10350756036812939
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0030516130000000003	0.10350756036812939
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09831392207388706
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09831392207388706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09831392207388706
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09831392207388706
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09831392207388706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09831392207388706
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09831392207388706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09831392207388706
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09831392207388706
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09817366714571557
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09817366714571557
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09817366714571557
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09817366714571557
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09817366714571557
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09817366714571557
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09817366714571557
LISSENCEPHALY 3; LIS3	0.002894359	0.09817366714571557
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09817366714571557
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09817366714571557
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09817366714571557
CYCLIC VOMITING SYNDROME	0.002894359	0.09817366714571557
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09817366714571557
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09817366714571557
47,XYY SYNDROME	0.002894359	0.09817366714571557
CAMOS SYNDROME	0.002894359	0.09817366714571557
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09817366714571557
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09817366714571557
PRADER-WILLI SYNDROME	0.002894359	0.09817366714571557
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09817366714571557
GABA-TRANSAMINASE DEFICIENCY	0.002892023	0.09809443243901458
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002892023	0.09809443243901458
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002892023	0.09809443243901458
611961 STEVENSON-CAREY SYNDROME	0.002892023	0.09809443243901458
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002892023	0.09809443243901458
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002892023	0.09809443243901458
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002892023	0.09809443243901458
MEVALONIC ACIDURIA	0.002892023	0.09809443243901458
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002892023	0.09809443243901458
LUSCAN-LUMISH SYNDROME; LLS	0.002892023	0.09809443243901458
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002892023	0.09809443243901458
XQ25 DUPLICATION SYNDROME	0.002718293	0.09220169031779701
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.09220169031779701
DISTAL MONOSOMY 1Q	0.002718293	0.09220169031779701
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.09220169031779701
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002718293	0.09220169031779701
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.09220169031779701
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0027182929999999997	0.09220169031779699
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0027182929999999997	0.09220169031779699
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0027182929999999997	0.09220169031779699
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0027182929999999997	0.09220169031779699
19P13.12 MICRODELETION SYNDROME	0.0027182929999999997	0.09220169031779699
TRISOMY X	0.0027182929999999997	0.09220169031779699
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.0027182929999999997	0.09220169031779699
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0027182929999999997	0.09220169031779699
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0027182929999999997	0.09220169031779699
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09167279186677446
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09167279186677446
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09167279186677446
BRUCK SYNDROME 2	0.0027026999999999997	0.09167279186677446
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09167279186677446
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09167279186677446
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09167279186677446
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09167279186677446
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09167279186677446
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09167279186677446
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09167279186677446
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09167279186677446
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09167279186677446
INIENCEPHALY	0.0027026999999999997	0.09167279186677446
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09167279186677446
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09167279186677446
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09167279186677446
BRUCK SYNDROME	0.0027026999999999997	0.09167279186677446
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09167279186677446
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677446
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09167279186677446
CLOACAL EXSTROPHY	0.0027026999999999997	0.09167279186677446
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09167279186677446
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09167279186677446
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09167279186677446
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677446
TIBIAL HEMIMELIA	0.0027026999999999997	0.09167279186677446
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09167279186677446
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09167279186677446
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09167279186677446
RENAL AGENESIS	0.0027026999999999997	0.09167279186677446
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677446
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09167279186677446
LAMBERT SYNDROME	0.0027026999999999997	0.09167279186677446
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09167279186677446
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677446
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677446
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09167279186677446
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09167279186677446
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09167279186677446
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09167279186677446
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09167279186677446
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09167279186677446
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09167279186677446
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09167279186677446
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09167279186677446
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09167279186677446
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09167279186677446
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09167279186677446
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09167279186677446
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09167279186677446
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09167279186677446
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09167279186677446
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09167279186677446
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09167279186677446
NIEVERGELT SYNDROME	0.0027026999999999997	0.09167279186677446
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09167279186677446
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09167279186677446
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09167279186677446
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09167279186677446
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09167279186677446
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09167279186677446
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09167279186677446
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09167279186677446
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09167279186677446
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09167279186677446
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08801069668540465
TEMTAMY SYNDROME	0.0025947339999999996	0.08801069668540465
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08801069668540465
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08801069668540465
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08801069668540465
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08801069668540465
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08801069668540465
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540465
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540465
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08801069668540465
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08801069668540465
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08801069668540465
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08801069668540465
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08801069668540465
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08787044175723316
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08787044175723316
CRANIOSYNOSTOSIS 2	0.002590599	0.08787044175723316
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08787044175723316
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08787044175723316
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08787044175723316
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08514318722286088
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08514318722286088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08514318722286088
STEEL SYNDROME; STLS	0.0025101940000000003	0.08514318722286088
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08514318722286088
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08514318722286088
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08514318722286088
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08514318722286088
PENTASOMY X	0.0025101940000000003	0.08514318722286088
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08514318722286088
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08514318722286088
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08514318722286088
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08514318722286088
FILIPPI SYNDROME; FLPIS	0.002506059	0.08500293229468937
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08500293229468937
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08500293229468937
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08500293229468937
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08500293229468937
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08500293229468937
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08500293229468937
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08500293229468937
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.07980929400044708
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.07980929400044708
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.07980929400044708
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.07980929400044708
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.07980929400044708
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044708
SENGERS SYNDROME	0.00235294	0.07980929400044708
TEMPLE SYNDROME	0.00235294	0.07980929400044708
USHER SYNDROME, TYPE IF	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.07980929400044708
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.07980929400044708
BETHLEM MYOPATHY 1	0.00235294	0.07980929400044708
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.07980929400044708
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.07980929400044708
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.07980929400044708
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.07980929400044708
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.07980929400044708
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.07980929400044708
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.07980929400044708
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.07980929400044708
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.07980929400044708
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.07980929400044708
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.07980929400044708
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.07980929400044708
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.07980929400044708
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.07980929400044708
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.07980929400044708
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.07980929400044708
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.07980929400044708
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.07980929400044708
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.07980929400044708
BRUNNER SYNDROME; BRNRS	0.00235294	0.07980929400044708
GILLESPIE SYNDROME; GLSP	0.00235294	0.07980929400044708
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.07980929400044708
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.07980929400044708
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.07980929400044708
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.07980929400044708
AMISH NEMALINE MYOPATHY	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.07980929400044708
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.07980929400044708
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.07980929400044708
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.07980929400044708
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.07980929400044708
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.07980929400044708
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.07980929400044708
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.07980929400044708
SALIH MYOPATHY; SALMY	0.00235294	0.07980929400044708
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.07980929400044708
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.07980929400044708
TEMPLE SYNDROME	0.00235294	0.07980929400044708
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.07980929400044708
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.07980929400044708
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.07980929400044708
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.07980929400044708
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.07980929400044708
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.07980929400044708
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.07980929400044708
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044708
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.07980929400044708
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.07980929400044708
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.07980929400044708
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.07980929400044708
SILVER-RUSSELL SYNDROME	0.00235294	0.07980929400044708
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.07980929400044708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.07980929400044708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.07980929400044708
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.07980929400044708
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.07980929400044708
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.07980929400044708
MEVALONIC ACIDURIA; MEVA	0.002350604	0.07973005929374609
NOONAN SYNDROME 9; NS9	0.002350604	0.07973005929374609
NOONAN SYNDROME 2; NS2	0.002350604	0.07973005929374609
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.07973005929374609
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.07973005929374609
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.07973005929374609
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.07973005929374609
NOONAN SYNDROME 11; NS11	0.002350604	0.07973005929374609
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.07973005929374609
COLE-CARPENTER SYNDROME	0.002350604	0.07973005929374609
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.07973005929374609
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.07973005929374609
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.07973005929374609
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.0795898043655746
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.0795898043655746
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.0795898043655746
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.0795898043655746
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.0795898043655746
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.0795898043655746
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.0795898043655746
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.0795898043655746
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.0738373171725285
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.0738373171725285
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.0738373171725285
48,XYYY SYNDROME	0.0021768739999999996	0.0738373171725285
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.0738373171725285
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.0738373171725285
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.0738373171725285
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.0738373171725285
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.0738373171725285
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.0738373171725285
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.0738373171725285
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.0738373171725285
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.0738373171725285
KNOBLOCH SYNDROME	0.002172739	0.07369706224435701
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.07369706224435701
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.07369706224435701
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.06950606861196466
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196466
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.06950606861196466
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.06950606861196466
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.06950606861196466
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.06950606861196466
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.06950606861196466
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.06950606861196466
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.06950606861196466
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.06950606861196466
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.06950606861196466
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.06950606861196466
OPSISMODYSPLASIA	0.00204918	0.06950606861196466
PYCNODYSOSTOSIS	0.00204918	0.06950606861196466
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.06950606861196466
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.06950606861196466
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.06950606861196466
CHITAYAT SYNDROME	0.00204918	0.06950606861196466
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.06950606861196466
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.06950606861196466
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196466
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.06950606861196466
JEUNE SYNDROME	0.00204918	0.06950606861196466
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.06950606861196466
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.06950606861196466
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.06950606861196466
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.06950606861196466
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.06950606861196466
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.06950606861196466
SMITH-MAGENIS SYNDROME	0.00204918	0.06950606861196466
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.06950606861196466
LARSEN SYNDROME	0.00204918	0.06950606861196466
2Q37 MONOSOMY	0.00204918	0.06950606861196466
WEILL-MARCHESANI SYNDROME	0.00204918	0.06950606861196466
SATOYOSHI SYNDROME	0.00204918	0.06950606861196466
TETRALOGY OF FALLOT	0.00204918	0.06950606861196466
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.06950606861196466
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.06950606861196466
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.06950606861196466
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.06950606861196466
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.06950606861196466
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196466
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.06950606861196466
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.06950606861196466
LOWRY-WOOD SYNDROME	0.00204918	0.06950606861196466
GRANGE SYNDROME; GRNG	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.06950606861196466
PROXIMAL SYMPHALANGISM	0.00204918	0.06950606861196466
RHYNS SYNDROME; RHYNS	0.00204918	0.06950606861196466
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.06950606861196466
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.06950606861196466
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.06950606861196466
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.06950606861196466
HYPOCHONDROPLASIA	0.00204918	0.06950606861196466
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196466
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.06950606861196466
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.06950606861196466
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.06950606861196466
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.06950606861196466
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.06950606861196466
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.06950606861196466
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.06950606861196466
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.06950606861196466
ROIFMAN SYNDROME	0.00204918	0.06950606861196466
FEINGOLD SYNDROME	0.00204918	0.06950606861196466
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.06950606861196466
PERIPHERAL DYSOSTOSIS	0.00204918	0.06950606861196466
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.06950606861196466
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.06950606861196466
ACROMICRIC DYSPLASIA	0.00204918	0.06950606861196466
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.06950606861196466
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.06950606861196466
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.06950606861196466
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.06950606861196466
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.06950606861196466
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.06950606861196466
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.06950606861196466
PYCNODYSOSTOSIS	0.00204918	0.06950606861196466
GREENBERG DYSPLASIA	0.00204918	0.06950606861196466
CAMPOMELIA, CUMMING TYPE	0.00204918	0.06950606861196466
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196466
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.06950606861196466
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.06950606861196466
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.06950606861196466
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.06950606861196466
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.06950606861196466
EIKEN SYNDROME	0.00204918	0.06950606861196466
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.06950606861196466
METATROPIC DYSPLASIA	0.00204918	0.06950606861196466
ENG-STROM SYNDROME	0.00204918	0.06950606861196466
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.06950606861196466
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.06950606861196466
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.06950606861196466
HEART-HAND SYNDROME TYPE 3	0.00204918	0.06950606861196466
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.06950606861196466
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.06950606861196466
HYPOCHONDROPLASIA	0.00204918	0.06950606861196466
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.06950606861196466
RADIO-RENAL SYNDROME	0.00204918	0.06950606861196466
EMERY-NELSON SYNDROME	0.00204918	0.06950606861196466
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.06950606861196466
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.06950606861196466
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.06950606861196466
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.06950606861196466
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.06950606861196466
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.06950606861196466
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.06950606861196466
ISOLATED BRACHYCEPHALY	0.00204918	0.06950606861196466
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.06950606861196466
COOKS SYNDROME	0.00204918	0.06950606861196466
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.06950606861196466
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.06950606861196466
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.06950606861196466
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196466
BANKI SYNDROME	0.00204918	0.06950606861196466
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.06950606861196466
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.06950606861196466
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.06950606861196466
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.06950606861196466
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.06950606861196466
SYNDACTYLY, TYPE V	0.00204918	0.06950606861196466
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.06950606861196466
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.06950606861196466
SYMPHALANGISM, DISTAL	0.00204918	0.06950606861196466
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.06950606861196466
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06663855914942088
MULIBREY NANISM	0.00196464	0.06663855914942088
ISOLATED TRIGONOCEPHALY	0.00196464	0.06663855914942088
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06663855914942088
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942088
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06663855914942088
MECKEL SYNDROME 12; MKS12	0.00196464	0.06663855914942088
RETINITIS PIGMENTOSA	0.00196464	0.06663855914942088
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942088
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06663855914942088
MARSHALL SYNDROME	0.00196464	0.06663855914942088
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06663855914942088
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06663855914942088
FRONTONASAL DYSPLASIA	0.00196464	0.06663855914942088
MEGALENCEPHALY	0.00196464	0.06663855914942088
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06663855914942088
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06663855914942088
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06663855914942088
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06663855914942088
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06663855914942088
PIEBALDISM	0.00196464	0.06663855914942088
ZECHI-CEIDE SYNDROME	0.00196464	0.06663855914942088
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06663855914942088
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06663855914942088
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06663855914942088
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06663855914942088
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06663855914942088
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06663855914942088
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06663855914942088
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06663855914942088
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06663855914942088
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942088
BOOMERANG DYSPLASIA	0.00196464	0.06663855914942088
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06663855914942088
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06663855914942088
AXENFELD-RIEGER SYNDROME	0.00196464	0.06663855914942088
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06663855914942088
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06663855914942088
JUNG SYNDROME	0.00196464	0.06663855914942088
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06663855914942088
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06663855914942088
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942088
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06663855914942088
NON-DISTAL TRISOMY 10Q	0.00180505	0.06122543122030608
HARTSFIELD SYNDROME	0.00180505	0.06122543122030608
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.06122543122030608
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.06122543122030608
RESTRICTIVE DERMOPATHY	0.00180505	0.06122543122030608
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.06122543122030608
TRISOMY 1Q	0.00180505	0.06122543122030608
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.06122543122030608
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.06122543122030608
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.06122543122030608
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030608
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.06122543122030608
PROTEUS-LIKE SYNDROME	0.00180505	0.06122543122030608
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.06122543122030608
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.06122543122030608
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.06122543122030608
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.06122543122030608
MARFAN SYNDROME; MFS	0.00180505	0.06122543122030608
RUVALCABA SYNDROME	0.00180505	0.06122543122030608
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.06122543122030608
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.06122543122030608
APERT SYNDROME	0.00180505	0.06122543122030608
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.06122543122030608
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.06122543122030608
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030608
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.06122543122030608
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.06122543122030608
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.06122543122030608
CAT-EYE SYNDROME	0.00180505	0.06122543122030608
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.06122543122030608
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.06122543122030608
THOMAS SYNDROME	0.00180505	0.06122543122030608
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.06122543122030608
NOONAN SYNDROME 10; NS10	0.00180505	0.06122543122030608
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.06122543122030608
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.06122543122030608
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030608
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030608
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.06122543122030608
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.06122543122030608
MARFAN SYNDROME	0.00180505	0.06122543122030608
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.06122543122030608
PAI SYNDROME	0.00180505	0.06122543122030608
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.06122543122030608
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.06122543122030608
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.055332689099088506
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.055332689099088506
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.055332689099088506
LICHTENSTEIN SYNDROME	0.00163132	0.055332689099088506
FETAL VALPROATE SYNDROME	0.00163132	0.055332689099088506
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088506
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088506
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.055332689099088506
SCHOLTE SYNDROME; SHLTS	0.00163132	0.055332689099088506
RENAL AGENESIS, BILATERAL	0.00163132	0.055332689099088506
MONOSOMY X	0.00163132	0.055332689099088506
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.055332689099088506
TURNER SYNDROME	0.00163132	0.055332689099088506
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.055332689099088506
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.055332689099088506
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.055332689099088506
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.055332689099088506
EPICANTHUS	0.00163132	0.055332689099088506
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.055332689099088506
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.055332689099088506
PENOSCROTAL TRANSPOSITION	0.00163132	0.055332689099088506
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.055332689099088506
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.055332689099088506
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.055332689099088506
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.055332689099088506
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.055332689099088506
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.055332689099088506
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.055332689099088506
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.055332689099088506
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.055332689099088506
MOSAIC MONOSOMY X	0.00163132	0.055332689099088506
JUBERG-MARSIDI SYNDROME	0.00163132	0.055332689099088506
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.055332689099088506
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.055332689099088506
BRITTLE CORNEA SYNDROME	0.00163132	0.055332689099088506
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.055332689099088506
STICKLER SYNDROME	0.00163132	0.055332689099088506
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.055332689099088506
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.055332689099088506
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.055332689099088506
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.055332689099088506
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.055332689099088506
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.055332689099088506
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.036869001218708494
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.036869001218708494
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.036869001218708494
CLASSIC PHENYLKETONURIA	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.036869001218708494
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.036869001218708494
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.036869001218708494
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.036869001218708494
LEBER CONGENITAL AMAUROSIS	0.001086973	0.036869001218708494
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.036869001218708494
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.036869001218708494
ALSTRÖM SYNDROME	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.036869001218708494
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.036869001218708494
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.036869001218708494
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.036869001218708494
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.036869001218708494
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.036869001218708494
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.036869001218708494
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.036869001218708494
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.036869001218708494
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.036869001218708494
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.036869001218708494
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.036869001218708494
NETHERTON SYNDROME	0.001086973	0.036869001218708494
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.036869001218708494
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.036869001218708494
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.036869001218708494
ALG3-CDG	0.001086973	0.036869001218708494
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.036869001218708494
PFEIFFER SYNDROME TYPE 2	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.036869001218708494
ALG1-CDG	0.001086973	0.036869001218708494
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.036869001218708494
GAUCHER DISEASE, TYPE II	0.001086973	0.036869001218708494
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.036869001218708494
MAPLE SYRUP URINE DISEASE	0.001086973	0.036869001218708494
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.036869001218708494
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.036869001218708494
2P21 MICRODELETION SYNDROME	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.036869001218708494
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.036869001218708494
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.036869001218708494
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.036869001218708494
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.036869001218708494
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.036869001218708494
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.036869001218708494
COACH SYNDROME	0.001086973	0.036869001218708494
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.036869001218708494
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.036869001218708494
HARTNUP DISORDER	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.036869001218708494
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.036869001218708494
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.036869001218708494
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.036869001218708494
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.036869001218708494
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.036869001218708494
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.036869001218708494
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.036869001218708494
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.036869001218708494
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.036869001218708494
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.036869001218708494
CRANIOPHARYNGIOMA	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.036869001218708494
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.036869001218708494
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.036869001218708494
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.036869001218708494
ELEJALDE DISEASE	0.001086973	0.036869001218708494
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.036869001218708494
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.036869001218708494
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.036869001218708494
LEIGH SYNDROME; LS	0.001086973	0.036869001218708494
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.036869001218708494
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.036869001218708494
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.036869001218708494
ARGININOSUCCINIC ACIDURIA	0.001086973	0.036869001218708494
WYBURN-MASON SYNDROME	0.001086973	0.036869001218708494
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.036869001218708494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.036869001218708494
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.036869001218708494
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.036869001218708494
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.036869001218708494
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.036869001218708494
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.036869001218708494
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.036869001218708494
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.036869001218708494
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.036869001218708494
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.036869001218708494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.036869001218708494
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.036869001218708494
CITRULLINEMIA, CLASSIC	0.001086973	0.036869001218708494
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.036869001218708494
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.036869001218708494
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.036869001218708494
PROPIONIC ACIDEMIA	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.036869001218708494
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.036869001218708494
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.036869001218708494
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.036869001218708494
PHACE ASSOCIATION	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.036869001218708494
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.036869001218708494
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.036869001218708494
LISSENCEPHALY 1; LIS1	0.001086973	0.036869001218708494
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.036869001218708494
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.036869001218708494
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.036869001218708494
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.036869001218708494
CONGENITAL TOXOPLASMOSIS	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.036869001218708494
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.036869001218708494
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.036869001218708494
DPAGT1-CDG	0.001086973	0.036869001218708494
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.036869001218708494
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.036869001218708494
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.036869001218708494
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.036869001218708494
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.036869001218708494
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.036869001218708494
GALACTOSEMIA	0.001086973	0.036869001218708494
FUCOSIDOSIS	0.001086973	0.036869001218708494
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.036869001218708494
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.036869001218708494
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.036869001218708494
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.036869001218708494
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.036869001218708494
HYDRANENCEPHALY	0.001086973	0.036869001218708494
TIMOTHY SYNDROME; TS	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.036869001218708494
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.036869001218708494
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.036869001218708494
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.036869001218708494
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.036869001218708494
ISOVALERIC ACIDEMIA	0.001086973	0.036869001218708494
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.036869001218708494
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.036869001218708494
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.036869001218708494
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.036869001218708494
SRD5A3-CDG	0.001086973	0.036869001218708494
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.036869001218708494
SCHINDLER DISEASE, TYPE I	0.001086973	0.036869001218708494
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.036869001218708494
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.036869001218708494
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.036869001218708494
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.036869001218708494
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.036869001218708494
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.036869001218708494
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.036869001218708494
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.036869001218708494
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.036869001218708494
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.036869001218708494
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.036869001218708494
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.036869001218708494
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.036869001218708494
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.036869001218708494
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.036869001218708494
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.036869001218708494
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.036869001218708494
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.036869001218708494
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.036869001218708494
LISSENCEPHALY 4	0.001086973	0.036869001218708494
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.036869001218708494
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.036869001218708494
17Q12 MICRODELETION SYNDROME	0.001086973	0.036869001218708494
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.036869001218708494
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.036869001218708494
XP21 MICRODELETION SYNDROME	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.036869001218708494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.036869001218708494
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.036869001218708494
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.036869001218708494
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.036869001218708494
RFT1-CDG	0.001086973	0.036869001218708494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.036869001218708494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.036869001218708494
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.036869001218708494
CITRULLINEMIA TYPE II	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.036869001218708494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.036869001218708494
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.036869001218708494
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.036869001218708494
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.036869001218708494
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.036869001218708494
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.036869001218708494
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.036869001218708494
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.036869001218708494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.036869001218708494
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.036869001218708494
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.036869001218708494
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.036869001218708494
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.036869001218708494
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.036869001218708494
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.036869001218708494
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.036869001218708494
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.036869001218708494
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.036869001218708494
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.036869001218708494
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.036869001218708494
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.036869001218708494
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.036869001218708494
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.036869001218708494
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.036869001218708494
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.036869001218708494
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.036869001218708494
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.036869001218708494
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.036869001218708494
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.036869001218708494
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.036869001218708494
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.036869001218708494
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.036869001218708494
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.036869001218708494
EAST SYNDROME	0.001086973	0.036869001218708494
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.036869001218708494
GRISCELLI SYNDROME	0.001086973	0.036869001218708494
STT3A-CDG	0.001086973	0.036869001218708494
STT3B-CDG	0.001086973	0.036869001218708494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.036869001218708494
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.036869001218708494
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.036869001218708494
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.036869001218708494
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.036869001218708494
COFFIN-SIRIS SYNDROME 5	0.001086973	0.036869001218708494
SULFOCYSTEINURIA	0.001086973	0.036869001218708494
KEUTEL SYNDROME	0.001086973	0.036869001218708494
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.036869001218708494
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.036869001218708494
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.036869001218708494
OPTIC PATHWAY GLIOMA	0.001086973	0.036869001218708494
ALG6-CDG	0.000545554	0.018504628073439996
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.018504628073439996
NAVAJO NEUROHEPATOPATHY	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.018504628073439996
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018504628073439996
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.018504628073439996
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.018504628073439996
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.018504628073439996
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.018504628073439996
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.018504628073439996
CONGENITAL VARICELLA SYNDROME	0.000545554	0.018504628073439996
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.018504628073439996
JOUBERT SYNDROME 6	0.000545554	0.018504628073439996
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.018504628073439996
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.018504628073439996
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.018504628073439996
JOUBERT SYNDROME 7	0.000545554	0.018504628073439996
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.018504628073439996
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.018504628073439996
JOUBERT SYNDROME 27	0.000545554	0.018504628073439996
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.018504628073439996
JOUBERT SYNDROME 25	0.000545554	0.018504628073439996
8P23.1 DUPLICATION SYNDROME	0.000545554	0.018504628073439996
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439996
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.018504628073439996
TYSHCHENKO SYNDROME	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.018504628073439996
ATHYREOSIS	0.000545554	0.018504628073439996
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.018504628073439996
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.018504628073439996
MUCOLIPIDOSIS IV; ML4	0.000545554	0.018504628073439996
REVESZ SYNDROME	0.000545554	0.018504628073439996
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.018504628073439996
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.018504628073439996
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439996
HOLOPROSENCEPHALY 11	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.018504628073439996
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.018504628073439996
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.018504628073439996
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.018504628073439996
TRANSALDOLASE DEFICIENCY	0.000545554	0.018504628073439996
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.018504628073439996
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.018504628073439996
SENIOR-LOKEN SYNDROME 9	0.000545554	0.018504628073439996
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.018504628073439996
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.018504628073439996
JOUBERT SYNDROME 28	0.000545554	0.018504628073439996
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.018504628073439996
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439996
NETHERTON SYNDROME; NETH	0.000545554	0.018504628073439996
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA	0.000545554	0.018504628073439996
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.018504628073439996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.018504628073439996
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.018504628073439996
JOUBERT SYNDROME 26	0.000545554	0.018504628073439996
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.018504628073439996
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.018504628073439996
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.018504628073439996
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.018504628073439996
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.018504628073439996
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439996
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.018504628073439996
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.018504628073439996
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.018504628073439996
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.018504628073439996
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439996
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.018504628073439996
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.018504628073439996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.018504628073439996
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.018504628073439996
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.018504628073439996
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.018504628073439996
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.018504628073439996
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.018504628073439996
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.018504628073439996
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.018504628073439996
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.018504628073439996
JOUBERT SYNDROME 15	0.000545554	0.018504628073439996
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.018504628073439996
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.018504628073439996
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.018504628073439996
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.018504628073439996
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.018504628073439996
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.018504628073439996
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.018504628073439996
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.018504628073439996
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.018504628073439996
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.018504628073439996
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.018504628073439996
OROTIC ACIDURIA	0.000545554	0.018504628073439996
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.018504628073439996
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.018504628073439996
WOLMAN DISEASE	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.018504628073439996
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.018504628073439996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.018504628073439996
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.018504628073439996
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.018504628073439996
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.018504628073439996
JOUBERT SYNDROME 8	0.000545554	0.018504628073439996
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.018504628073439996
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.018504628073439996
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.018504628073439996
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.018504628073439996
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.018504628073439996
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.018504628073439996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.018504628073439996
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.018504628073439996
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.018504628073439996
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.018504628073439996
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.018504628073439996
PELLAGRA-LIKE SYNDROME	0.000545554	0.018504628073439996
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.018504628073439996
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.018504628073439996
WAARDENBURG-SHAH SYNDROME	0.000545554	0.018504628073439996
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.018504628073439996
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.018504628073439996
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.018504628073439996
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.018504628073439996
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.018504628073439996
FARBER DISEASE	0.000545554	0.018504628073439996
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.018504628073439996
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.018504628073439996
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.018504628073439996
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.018504628073439996
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439996
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.018504628073439996
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.018504628073439996
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.018504628073439996
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.018504628073439996
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.018504628073439996
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.018504628073439996
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.018504628073439996
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.018504628073439996
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.018504628073439996
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.018504628073439996
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.018504628073439996
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439996
BARDET-BIEDL SYNDROME 2	0.000545554	0.018504628073439996
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.018504628073439996
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.018504628073439996
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.018504628073439996
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.018504628073439996
CDAGS SYNDROME	0.000545554	0.018504628073439996
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.018504628073439996
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.018504628073439996
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.018504628073439996
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.018504628073439996
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.018504628073439996
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.018504628073439996
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.018504628073439996
CURRY-JONES SYNDROME	0.000545554	0.018504628073439996
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.018504628073439996
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.018504628073439996
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.018504628073439996
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.018504628073439996
YUNIS-VARON SYNDROME	0.000545554	0.018504628073439996
LOWRY-MACLEAN SYNDROME	0.000545554	0.018504628073439996
PROPIONIC ACIDEMIA	0.000545554	0.018504628073439996
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.018504628073439996
ISOLATED PLAGIOCEPHALY	0.000545554	0.018504628073439996
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.018504628073439996
EPIDERMAL NEVUS SYNDROME	0.000545554	0.018504628073439996
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439996
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.018504628073439996
ARIMA SYNDROME	0.000545554	0.018504628073439996
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.018504628073439996
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.018504628073439996
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.018504628073439996
MECKEL SYNDROME 13; MKS13	0.000545554	0.018504628073439996
TRANSKETOLASE DEFICIENCY	0.000545554	0.018504628073439996
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.018504628073439996
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.018504628073439996
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.018504628073439996
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.018504628073439996
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.018504628073439996
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.018504628073439996
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.018504628073439996
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.018504628073439996
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.018504628073439996
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.018504628073439996
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.018504628073439996
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.018504628073439996
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.018504628073439996
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.018504628073439996
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.018504628073439996
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.018504628073439996
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.018504628073439996
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.018504628073439996
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.018504628073439996
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.018504628073439996
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.018504628073439996
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.018504628073439996
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.018504628073439996
SENIOR-LOKEN SYNDROME	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.018504628073439996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.018504628073439996
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.018504628073439996
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.018504628073439996
SECKEL SYNDROME 8; SCKL8	0.000545554	0.018504628073439996
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.018504628073439996
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.018504628073439996
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.018504628073439996
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.018504628073439996
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.018504628073439996
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.018504628073439996
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.018504628073439996
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.018504628073439996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.018504628073439996
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.018504628073439996
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.018504628073439996
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.018504628073439996
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.018504628073439996
SEPTOOPTIC DYSPLASIA	0.000545554	0.018504628073439996
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.018504628073439996
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.018504628073439996
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.018504628073439996
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.018504628073439996
JOUBERT SYNDROME 21	0.000545554	0.018504628073439996
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.018504628073439996
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.018504628073439996
USHER SYNDROME TYPE 1	0.000545554	0.018504628073439996
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.018504628073439996
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.018504628073439996
AUSTRALIA ANTIGEN	0.000545554	0.018504628073439996
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.018504628073439996
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.018504628073439996
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.018504628073439996
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.018504628073439996
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.018504628073439996
CURRARINO SYNDROME	0.000545554	0.018504628073439996
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.018504628073439996
THYROID HYPOPLASIA	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.018504628073439996
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.018504628073439996
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.018504628073439996
CULLER-JONES SYNDROME; CJS	0.000545554	0.018504628073439996
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.018504628073439996
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.018504628073439996
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439996
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.018504628073439996
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.018504628073439996
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.018504628073439996
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.018504628073439996
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.018504628073439996
LIG4 SYNDROME	0.000545554	0.018504628073439996
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.018504628073439996
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.018504628073439996
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.018504628073439996
MICROVILLUS INCLUSION DISEASE	0.000545554	0.018504628073439996
ALSTROM SYNDROME; ALMS	0.000545554	0.018504628073439996
SJÖGREN-LARSSON SYNDROME	0.000541419	0.0183643731452685
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.0183643731452685
ADDISON DISEASE	0.000541419	0.0183643731452685
FETAL GAUCHER DISEASE	0.000541419	0.0183643731452685
INSULINOMA	0.000541419	0.0183643731452685
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.0183643731452685
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.0183643731452685
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.0183643731452685
HADDAD SYNDROME	0.000541419	0.0183643731452685
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.0183643731452685
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.0183643731452685
PFEIFFER SYNDROME TYPE 3	0.000541419	0.0183643731452685
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.0183643731452685
LASSA FEVER	0.000541419	0.0183643731452685
NIPAH VIRUS DISEASE	0.000541419	0.0183643731452685
ENCEPHALITIS LETHARGICA	0.000541419	0.0183643731452685
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.0183643731452685
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.0183643731452685
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.0183643731452685
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.0183643731452685
TRIPLE A SYNDROME	0.000541419	0.0183643731452685
SYSTEMIC SCLEROSIS	0.000541419	0.0183643731452685
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.0183643731452685
SCRUB TYPHUS	0.000541419	0.0183643731452685
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.0183643731452685
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.0183643731452685
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.0183643731452685
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.0183643731452685
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.0183643731452685
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.0183643731452685
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.0183643731452685
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.0183643731452685
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.0183643731452685
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.0183643731452685
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.0183643731452685
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.0183643731452685
GURRIERI SYNDROME	0.000541419	0.0183643731452685
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.0183643731452685
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.0183643731452685
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.0183643731452685
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.0183643731452685
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.0183643731452685
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.0183643731452685
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.0183643731452685
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.0183643731452685
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.0183643731452685
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.0183643731452685
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.0183643731452685
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.0183643731452685
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.0183643731452685
THREONINEMIA	0.000541419	0.0183643731452685
THYROCEREBRORETINAL SYNDROME	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.0183643731452685
ADRENOLEUKODYSTROPHY	0.000541419	0.0183643731452685
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.0183643731452685
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.0183643731452685
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.0183643731452685
INCONTINENTIA PIGMENTI; IP	0.000541419	0.0183643731452685
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.0183643731452685
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.0183643731452685
IMMUNODEFICIENCY 47	0.000541419	0.0183643731452685
FABRY DISEASE	0.000541419	0.0183643731452685
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.0183643731452685
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.0183643731452685
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.0183643731452685
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.0183643731452685
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.0183643731452685
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.0183643731452685
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.0183643731452685
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.0183643731452685
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.0183643731452685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.0183643731452685
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.0183643731452685
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.0183643731452685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.0183643731452685
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.0183643731452685
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.0183643731452685
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.0183643731452685
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.0183643731452685
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.0183643731452685
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.0183643731452685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.0183643731452685
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.0183643731452685
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.0183643731452685
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.0183643731452685
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.0183643731452685
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.0183643731452685
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.0183643731452685
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.0183643731452685
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.0183643731452685
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.0183643731452685
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.0183643731452685
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.0183643731452685
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.0183643731452685
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.0183643731452685
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.0183643731452685
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.0183643731452685
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.0183643731452685
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.0183643731452685
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.0183643731452685
COWDEN SYNDROME 6; CWS6	0.000541419	0.0183643731452685
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.0183643731452685
PERRAULT SYNDROME 3	0.000541419	0.0183643731452685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.0183643731452685
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.0183643731452685
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.0183643731452685
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.0183643731452685
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.0183643731452685
COWDEN SYNDROME 5; CWS5	0.000541419	0.0183643731452685
TAY-SACHS DISEASE; TSD	0.000541419	0.0183643731452685
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.0183643731452685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.0183643731452685
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.0183643731452685
SNEDDON SYNDROME	0.000541419	0.0183643731452685
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.0183643731452685
STURGE-WEBER SYNDROME	0.000541419	0.0183643731452685
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.0183643731452685
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.0183643731452685
ALEXANDER DISEASE	0.000541419	0.0183643731452685
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.0183643731452685
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.0183643731452685
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.0183643731452685
PARIETAL FORAMINA	0.000541419	0.0183643731452685
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.0183643731452685
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.0183643731452685
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.0183643731452685
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.0183643731452685
DIAMINOPENTANURIA	0.000541419	0.0183643731452685
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.0183643731452685
DYSOSTEOSCLEROSIS	0.000541419	0.0183643731452685
EPILEPSY-TELANGIECTASIA	0.000541419	0.0183643731452685
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.0183643731452685
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.0183643731452685
FOUNTAIN SYNDROME	0.000541419	0.0183643731452685
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.0183643731452685
1P36 MICRODELETION SYNDROME	0.000541419	0.0183643731452685
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.0183643731452685
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.0183643731452685
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.0183643731452685
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.0183643731452685
PAPILLORENAL SYNDROME	0.000541419	0.0183643731452685
CROUZON SYNDROME	0.000541419	0.0183643731452685
DARIER-WHITE DISEASE; DAR	0.000541419	0.0183643731452685
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.0183643731452685
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.0183643731452685
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.0183643731452685
FLYNN-AIRD SYNDROME	0.000541419	0.0183643731452685
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.0183643731452685
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.0183643731452685
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.0183643731452685
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.0183643731452685
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.0183643731452685
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.0183643731452685
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.0183643731452685
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.0183643731452685
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.0183643731452685
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.0183643731452685
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.0183643731452685
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.0183643731452685
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.0183643731452685
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.0183643731452685
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.0183643731452685
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.0183643731452685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.0183643731452685
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.0183643731452685
NEURAMINIDASE DEFICIENCY	0.000541419	0.0183643731452685
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.0183643731452685
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.0183643731452685
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.0183643731452685
PHENYLKETONURIA	0.000541419	0.0183643731452685
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.0183643731452685
GITELMAN SYNDROME	0.000541419	0.0183643731452685
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.0183643731452685
RAMON SYNDROME	0.000541419	0.0183643731452685
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.0183643731452685
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.0183643731452685
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.0183643731452685
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.0183643731452685
HYPERPROLINEMIA, TYPE II	0.000541419	0.0183643731452685
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.0183643731452685
BERNARD-SOULIER SYNDROME	0.000541419	0.0183643731452685
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.0183643731452685
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.0183643731452685
HYPER-BETA-ALANINEMIA	0.000541419	0.0183643731452685
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.0183643731452685
HYPERLYSINEMIA, TYPE I	0.000541419	0.0183643731452685
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.0183643731452685
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.0183643731452685
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.0183643731452685
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.0183643731452685
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.0183643731452685
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.0183643731452685
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.0183643731452685
KAPUR-TORIELLO SYNDROME	0.000541419	0.0183643731452685
KIFAFA SEIZURE DISORDER	0.000541419	0.0183643731452685
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.0183643731452685
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.0183643731452685
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.0183643731452685
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.0183643731452685
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.0183643731452685
WOLFRAM SYNDROME	0.000541419	0.0183643731452685
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.0183643731452685
TAKAYASU ARTERITIS	0.000541419	0.0183643731452685
MERCURY POISONING	0.000541419	0.0183643731452685
THYROCEREBRORENAL SYNDROME	0.000541419	0.0183643731452685
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.0183643731452685
VIRAL HEMORRHAGIC FEVER	0.000541419	0.0183643731452685
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.0183643731452685
WHIPPLE DISEASE	0.000541419	0.0183643731452685
WORSTER-DROUGHT SYNDROME	0.000541419	0.0183643731452685
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.0183643731452685
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.0183643731452685
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.0183643731452685
GALACTOSIALIDOSIS	0.000541419	0.0183643731452685
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.0183643731452685
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.0183643731452685
GLIOBLASTOMA	0.000541419	0.0183643731452685
ADIPOSIS DOLOROSA	0.000541419	0.0183643731452685
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.0183643731452685
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.0183643731452685
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.0183643731452685
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.0183643731452685
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.0183643731452685
TYROSINEMIA TYPE 2	0.000541419	0.0183643731452685
CONGENITAL RUBELLA SYNDROME	0.000541419	0.0183643731452685
CRONKHITE-CANADA SYNDROME	0.000541419	0.0183643731452685
PORENCEPHALY	0.000541419	0.0183643731452685
PROLACTINOMA	0.000541419	0.0183643731452685
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.0183643731452685
RAMON SYNDROME	0.000541419	0.0183643731452685
ISOLATED BILIARY ATRESIA	0.000541419	0.0183643731452685
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.0183643731452685
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.0183643731452685
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.0183643731452685
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.0183643731452685
NOCARDIOSIS	0.000541419	0.0183643731452685
LUJO HEMORRHAGIC FEVER	0.000541419	0.0183643731452685
EBOLA HEMORRHAGIC FEVER	0.000541419	0.0183643731452685
RIFT VALLEY FEVER	0.000541419	0.0183643731452685
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.0183643731452685
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.0183643731452685
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.0183643731452685
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.0183643731452685
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.0183643731452685
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.0183643731452685
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.0183643731452685
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.0183643731452685
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.0183643731452685
EPISODIC ATAXIA TYPE 3	0.000541419	0.0183643731452685
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.0183643731452685
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.0183643731452685
HEREDITARY COPROPORPHYRIA	0.000541419	0.0183643731452685
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.0183643731452685
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.0183643731452685
FAMILIAL THROMBOCYTOSIS	0.000541419	0.0183643731452685
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.0183643731452685
MPDU1-CDG	0.000541419	0.0183643731452685
ALG2-CDG	0.000541419	0.0183643731452685
ALG9-CDG	0.000541419	0.0183643731452685
MOGS-CDG	0.000541419	0.0183643731452685
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.0183643731452685
PORPHYRIA VARIEGATA	0.000541419	0.0183643731452685
GRISCELLI SYNDROME TYPE 2	0.000541419	0.0183643731452685
PORPHYRIA	0.000541419	0.0183643731452685
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.0183643731452685
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.0183643731452685
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.0183643731452685
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.0183643731452685
HYPERPROLINEMIA TYPE 1	0.000541419	0.0183643731452685
HYPOPHOSPHATASIA	0.000541419	0.0183643731452685
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.0183643731452685
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.0183643731452685
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.0183643731452685
WHIM SYNDROME	0.000541419	0.0183643731452685
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.0183643731452685
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.0183643731452685
ONDINE SYNDROME	0.000541419	0.0183643731452685
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.0183643731452685
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.0183643731452685
MYASTHENIA GRAVIS	0.000541419	0.0183643731452685
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.0183643731452685
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.0183643731452685
RECURRENT ACUTE PANCREATITIS	0.000541419	0.0183643731452685
NEVUS COMEDONICUS SYNDROME	0.000541419	0.0183643731452685
LHERMITTE-DUCLOS DISEASE	0.000541419	0.0183643731452685
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.0183643731452685
NASU-HAKOLA DISEASE	0.000541419	0.0183643731452685
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.0183643731452685
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.0183643731452685
ROMANO-WARD SYNDROME	0.000541419	0.0183643731452685
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.0183643731452685
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.0183643731452685
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.0183643731452685
BETA-MANNOSIDOSIS	0.000541419	0.0183643731452685
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.0183643731452685
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.0183643731452685
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.0183643731452685
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.0183643731452685
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.0183643731452685
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.0183643731452685
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.0183643731452685
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.0183643731452685
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.0183643731452685
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.0183643731452685
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.0183643731452685
CRISPONI SYNDROME	0.000541419	0.0183643731452685
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.0183643731452685
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.0183643731452685
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.0183643731452685
ROSAÏ-DORFMAN DISEASE	0.000541419	0.0183643731452685
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.0183643731452685
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.0183643731452685
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.0183643731452685
PSEUDO-TORCH SYNDROME 2	0.000541419	0.0183643731452685
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.0183643731452685
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.0183643731452685
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.0183643731452685
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.0183643731452685
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.0183643731452685
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.0183643731452685
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.0183643731452685
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.0183643731452685
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.0183643731452685
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.0183643731452685
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.0183643731452685
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.0183643731452685
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.0183643731452685
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.0183643731452685
MICROSPORIDIOSIS	0.000541419	0.0183643731452685
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.0183643731452685
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.0183643731452685
SANJAD-SAKATI SYNDROME	0.000541419	0.0183643731452685
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.0183643731452685
CITRULLINEMIA TYPE I	0.000541419	0.0183643731452685
AICA-RIBOSIDURIA	0.000541419	0.0183643731452685
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.0183643731452685
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.0183643731452685
MOYAMOYA DISEASE	0.000541419	0.0183643731452685
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.0183643731452685
MOYNAHAN SYNDROME	0.000541419	0.0183643731452685
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.0183643731452685
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.0183643731452685
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.0183643731452685
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.0183643731452685
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.0183643731452685
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.0183643731452685
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.0183643731452685
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.0183643731452685
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.0183643731452685
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.0183643731452685
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.0183643731452685
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.0183643731452685
CENTRAL DIABETES INSIPIDUS	0.000541419	0.0183643731452685
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.0183643731452685
FRONTAL ENCEPHALOCELE	0.000541419	0.0183643731452685
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.0183643731452685
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.0183643731452685
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.0183643731452685
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.0183643731452685
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.0183643731452685
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.0183643731452685
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.0183643731452685
CRIGLER-NAJJAR SYNDROME	0.000541419	0.0183643731452685
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.0183643731452685
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.0183643731452685
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.0183643731452685
EPISODIC ATAXIA TYPE 6	0.000541419	0.0183643731452685
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.0183643731452685
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.0183643731452685
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.0183643731452685
